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ABSTRACT 
        Detection of molecular interactions is critical for understanding many biological 
processes, for detecting disease biomarkers, and for screening drug candidates. 
Fluorescence-based approach can be problematic, especially when applied to the detection 
of small molecules. Various label-free techniques, such as surface plasmon resonance 
technique are sensitive to mass, making it extremely challenging to detect small molecules. 
In this thesis, novel detection methods for molecular interactions are described. 
        First, a simple detection paradigm based on reflectance interferometry is developed. 
This method is simple, low cost and can be easily applied for protein array detection. 
        Second, a label-free charge sensitive optical detection (CSOD) technique is developed 
for detecting of both large and small molecules. The technique is based on that most 
molecules relevant to biomedical research and applications are charged or partially charged. 
An optical fiber is dipped into the well of a microplate. It detects the surface charge of the 
fiber, which does not decrease with the size (mass) of the molecule, making it particularly 
attractive for studying small molecules. 
        Third, a method for mechanically amplification detection of molecular interactions 
(MADMI) is developed. It provides quantitative analysis of small molecules interaction 
with membrane proteins in intact cells. The interactions are monitored by detecting a 
mechanical deformation in the membrane induced by the molecular interactions. With this 
novel method small molecules and membrane proteins interaction in the intact cells can be 
detected. This new paradigm provides mechanical amplification of small interaction 
signals, allowing us to measure the binding kinetics of both large and small molecules with 
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membrane proteins, and to analyze heterogeneous nature of the binding kinetics between 
different cells, and different regions of a single cell. 
        Last, by tracking the cell membrane edge deformation, binding caused downstream 
event – granule secretory has been measured. This method focuses on the plasma 
membrane change when granules fuse with the cell. The fusion of granules increases the 
plasma membrane area and thus the cell edge expands. The expansion is localized at the 
vesicle release location. Granule size was calculated based on measured edge expansion. 
The membrane deformation due to the granule release is real-time monitored by this 
method. 
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CHAPTER 1 
INTRODUCTION AND BACKGROUND 
1.1 Introduction 
        Small molecules play an important role in biological system, as they have a variety of 
biological functions, serving as cell signaling molecules, as drugs in medicine and etc. 
Protein-protein interactions have a key role in biological functions and thus provide 
chances for small molecule drugs modulating the protein-protein interaction as a 
therapeutic intervention to treat the disease [1, 2]. Small molecules are the most popular 
form of drugs. According to US FDA’s Orange Book (for primarily small-molecule drugs) 
and the Center for Biologics Evaluation and Research (CBER) website (for biological 
drugs), among the 1,357 unique drugs, 1204 are ‘small-molecule drugs’ which account for 
about 88%, and only 166 are ‘biological’ drugs [3]. The number of newly approved ‘small-
molecule drugs’ every year also exceeds the ‘biological’ drugs. Accurate, efficient 
evaluation of biomolecular interactions is critical in the drug screening and development. 
Screening for a drug is likened to searching for a needle in a haystack [4]. Nowadays it is 
taking, on average, 13.5 years to discover a drug from target identification to approval [5]. 
From this point, in order to shorten the drug discovery time and reduce cost, 
instrumentation advances and experimental design improvement are necessary. 
        The receptor theory of drug action posits that a drug works only when it binds to its 
target receptor [6]. To study this binding process, usually binding affinity and kinetics are 
employed. Binding affinity, quantified by equilibrium dissociation constant KD, measures 
the extent to which a drug is bound to its receptor at equilibrium. Binding affinity could 
not quantify the rates at which a drug associates with or dissociates from its receptor, which 
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directly impact drug efficacy and safety. The rates are the binding kinetics. Obviously, it 
is important to directly measure the binding kinetics of a drug and its receptor in order to 
optimize drug efficacy [7].  
        To date, the most widely used technology uses labels, such as radio- or enzymatic- or 
fluorescent-labeling to report the binding of a ligand to its receptor. While popular and 
useful, the labeling step requires additional time and cost, and even worse, labeled 
approach can be problematic, especially when applied to the detection of small molecules, 
because the dye molecules can significantly alter the activities of small molecules, leading 
to inaccurate conclusions [8]. Various label-free techniques, such as surface plasmon 
resonance technique and micro- and nanomechanical biosensors have been developed, but 
their sensitivities diminish with the size of the molecule, making it extremely challenging 
to detect small molecules. 
        In this chapter, first detailed binding kinetics is discussed. Second current small 
molecule detection methods are briefly reviewed. 
1.2 Binding Kinetics 
        Binding kinetics which is quantified by association rate constant (kon), dissociation 
rate constant (koff) describes how fast a ligand binds to its receptor and how quickly it 
dissociates from its receptor. Consider a simple binding reaction between a ligand (L) and 
its receptor (R) to form a biomolecular complex (LR): 
𝐿 + 𝑅𝐿𝑅.                                                           (1.1) 
This reaction comprises a single elementary step – the binding (or unbinding) of drug 
without any intermediate states which is the first order binding kinetics.  
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        The binding affinity is described by the dissociation constant, KD, a ratio of the 
relevant concentrations at equilibrium: 
𝐾𝐷 =
[𝐿][𝑅]
[𝐿𝑅]
.                                                      (1.2) 
At equilibrium, the ligand concentration at which half of the receptor binding sites are 
occupied is equivalent to 𝐾𝐷(both in unit of moles per liter). 𝐾𝐷 is directly related to the 
free energy difference, ∆𝐺𝑑, between the bound and unbound states [6]. By measuring the 
ratio of the three concentrations of ligand, receptor and the formed complex, the 
equilibrium dissociation constant can be determined. The stronger the molecular binding, 
the smaller the dissociation constant. 𝐾𝐷  is mostly used quantification of non-covalent 
binding. However, some information is missing to have an overall picture of molecular 
interaction if we only depend on measuring 𝐾𝐷, because it is the ratio of two rates given as:  
𝐾𝐷 =
𝑘𝑜𝑓𝑓
𝑘𝑜𝑛
,                                                     (1.3) 
where 𝑘𝑜𝑛  and 𝑘𝑜𝑓𝑓  are the association rate constant and dissociation rate constant 
respectively.  
        To understand the importance of measuring binding kinetics in order to 
comprehensively study a molecular interaction, let’s consider two drugs (𝐿1  and 𝐿2 ) 
binding to the same receptor (R) with the same equilibrium dissociation constant 𝐾𝐷. We 
could not assess which drug is better in terms of efficacy and safety if we solely measure 
𝐾𝐷. It is possible that both on- and off-rates are slow for 𝐿1, while that are fast for 𝐿2. 
Notably, changes in 𝑘𝑜𝑓𝑓 can result in no measurable effect on 𝐾𝐷 if there is compensatory 
changes in 𝑘𝑜𝑛. The average time that a ligand stays bound to its receptor, the residence 
time, 𝑡𝑅 ≡ 1/𝑘𝑜𝑓𝑓. We lose at least the information that how long the ligands keep bound 
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to the receptors if we only measure 𝐾𝐷 while the residence time is important in affecting 
the efficacy of drugs [7].  
1.3 State of the Art 
        Currently most used assay methods are reviewed in this part. The methods fall into 
two catalogs: labeled and label-free methods. Labeled methods, including enzyme linked 
immunosorbent assay (ELISA), radioimmunoassay and etc. require some fluorescent 
labeling, radiolabeling or enzyme linking to report the ligand and receptor binding. The 
labeled detection strategy arises a lot issues. First, the labeling step makes the detection 
take more time and work. Second, the labeled tag may intervene with the interaction 
between ligand and receptor which leads to false negatives. Third, the hydrophobic 
fluorophores may have strong nonspecific adsorption on the background which causes false 
positive results. However, the labeled detection, i.e. fluorescence based detection or ELISA, 
is principally used in the high-throughput screening ‘hits’. It is mainly because these 
methods have high sensitivity (for example, ELISA has a sensitivity in the range of pM in 
antibody-antigen detection) and are easy to be operated parallel by automated robot system. 
        In contrast, in label-free detection, target molecules are not labeled or affected and are 
detected in their natural forms. This detection method allows for not only affinity 
measurement as fluorescence-based detection, but also real-time quantitative and kinetic 
measurement of molecular interaction. As discussed in section 1.2, binding kinetics is 
indispensable when we comprehensively study a reaction. There are many label-free 
approaches, including surface plasmon resonance (SPR) biosensors that translate mass into 
refractive index, microcantilevers that transduce biomolecular interactions into mechanical 
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bending, and silicon nanowire field effect transistors that measure intrinsic biomolecular 
charge. SPR and mechanical biosensors will be reviewed in section 1.3.2 and 1.3.3. 
1.3.1 Enzyme Linked Immunosorbent Assay (ELISA) 
        Enzyme labels in immunoassay was invited in the 1960s with the reporter label to be 
enzyme rather than radioactivity [9]. Nowadays ELISA is a gold standard for protein study. 
There are different strategies used in ELISA: direct, indirect, sandwich and 
competitive/inhibition ELISA (Figure 1.1). The direct ELISA uses an enzyme labeled 
primary antibody directly binding to the antigen for detection. Detected antigen can be non-
covalently adsorbed on the substrate or captured by the capture antibody immobilized on 
the assay plate. However the direct ELISA is not widely used though it requires less 
procedures. The reasons are multifold. First, primary antibodies may be adversely affected 
by the labeled enzymes. Second, labeling primary antibody for each detected antigen is 
time and cost consuming. Indirect ELISA uses an enzyme labeling secondary antibody to 
generate signal while primary antibody for the binding. In the indirect assay, the 
immunoreactivity of the primary antibody is retained because it is not labeled. And 
sensitivity is increased because each primary antibody contains several epitopes that can 
be bound by the labeled secondary antibody, allowing for signal amplification. However, 
extra incubation and washing steps are required. Sandwich assays—the biomolecule to be 
detected is sandwiched between the surface bound capture antibody and detecting antibody 
followed by enzyme linked secondary antibody—is mostly used in the protein detection. 
The sandwich assay provides high specificity in detection because the capture assay format 
excludes many nonspecific adsorbed proteins on the substrate. With a first antibody that 
has 1 nM affinity, an ELISA assay can detect proteins within a few pM concentration range 
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[10]. The advantages of ELISA are obvious that ELISA has high sensitivity and selectivity 
which can be used to detect proteins in physiological fluid like serum, blood. Simplicity to 
be automated makes ELISA well suitable in the HTS application. 
 
Figure 1. 1 Common ELISA formats. The antigen of interest is directly adsorbed on the 
assay plate or captured by the immobilized capture antibody. The antigen is detected by 
enzyme linked primary antibody (direct assay) or a matched set of unlabeled primary and 
conjugate secondary antibodies (indirect assay). [From Thermo Scientific at 
http://www.piercenet.com] 
        However, the limitations of ELISA are multifold. First, the secondary antibody 
detection makes ELISA usually take a few hours. The washing between every steps 
increases the repetitive labor. Second, as a labeled method, ELISA is an endpoint detection 
assay which is hard to get the binding kinetics. Third, for the study of interaction between 
small molecules and protein, the direct detection is difficult mainly because the small size 
limits the secondary antibody selection.  Usually two antibodies binding to one antigen can 
be found while hard for a small molecule. Also it is not feasible to link an enzyme to small 
molecules for direct ELISA. Not mentioning the difficulty in chemical conjugation, the big 
enzyme will greatly affect the interaction between the small molecule and the protein which 
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gives inaccurate information. In the study of low molecular weight inhibitor of protein-
protein interaction, ELISA is used in the competitive/ inhibition assay. Chen et al. reported 
several active compounds were identified inhibiting MDM2-p53 binding in an ELISA 
assay with IC50 of 10 to 20 µM [11]. 
1.3.2 Surface Plasmon Resonance 
        Surface plasmon resonance (SPR) biosensor nowadays is prevalent in label-free 
detection. SPR biosensors detect the binding molecules induced refractive index change 
within around 200nm range above the sensor surface. Neither target nor biorecognition 
molecules need to be labeled. SPR biosensor plays an important role in high content 
screening because it can offer real-time monitoring of molecular interaction and accurate 
kinetics of biomolecules binding. The study of small molecules with carbonic anhydrase II 
that compared SPR with the traditional measurement of stopped-flow fluorescence and 
isothermal titration showed that the kinetic parameters determined by SPR are in agreement 
with those solution-based measurement [12]. 
        Most of the SPR sensors developed to date use Kretschmann configuration to generate 
surface plasmon resonance [13] (Figure 1.2). A p-polarized light is incident upon a metal 
film through a prism. When the incident angle reaches resonant angle, the surface plasmons, 
which are collective oscillations of free electrons in a metallic film, are excited. The 
reflective light intensity goes to minimum because the excited surface plasma adsorb the 
incident light energy. The resonance angle is highly dependent on the refractive index of 
the medium near the metal film. When binding happens, the bound molecules change the 
refractive index which gives a resonance angle shift. By measuring angle shift, the binding 
events can be detected. Another measurement strategy is to fix the incident light angle, and 
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measure the reflective light intensity. According to the light intensity change, the molecular 
interaction can be monitored.   
 
Figure 1. 2 Kretschmann configuration. A p-polarized light is incident on the metal film 
through a prism. The reflected beam is collected and analyzed [14]. When binding event 
happens, the resonant angle shifts (i.e. from I to II). 
        The commercialized SPR sensors, taking the instrument from Biacore 
(http://www.biacore.com) as an example, are typically based on prism coupling and have 
a detection limit between 1×10-6 to 1×10-7 RIU and a mass surface density detection limit 
around 1 pg/mm2 [15].By using a bi-cell photodetector, the detection limit is improved an 
order of magnitude, i.e.  1×10-8  RIU [16]. With the improvement of experimental design, 
instruments and data processing, SPR-based biosensor can be used for routinely studying 
the direct binding of small molecules (<500 Daltons) to macromolecular targets [17, 18]. 
Drug screening by SPR also has been explored [19]. However, because of its limited 
throughput, SPR has been mainly used for focus-deck screening or secondary confirmation 
screening [20]. A small library of 47 compounds against a cellular prion protein generated 
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6 hits that have shown activity in a cell-based assay [21]. SPR has been applied to fragment-
based drug design (FBDD), a novel strategy. Fragment-based screening involves the 
selection, screening, and optimization of fragments. In FBDD, diverse set of very small, 
less complex compounds (molecular weight < 300) is tested by affinity-based methods. 
Perspicace et al. applied SPR technology to screen a library of 2226 molecules (fragments 
having low molecular weight between 100 and 300 Da) for binding to chymase, a serine 
protease. And 80 compounds showed up as positive screening hits [22]. The results 
demonstrated that the application of SPR technology as a filter in fragment screening can 
be achieved successfully. 
        One major challenge for applying SPR technology to small-molecule drug discovery 
is the limit of detection. The change of refractive index depends on the mass change. When 
scaling down, it is hard to detect very low molecular weight molecules. Sometimes 
refractive index change is also due to conformational change of protein when binding to 
compounds. It can be used as another useful approach for small molecule detection, while 
it may not be broadly applied to a wide range of targets. 
1.3.3 Mechanical Biosensors 
        Advances in micro- and nonafabrication technologies are enabling a wide range of 
new technologies, including fabricating a micro- or nanosized mechanical moving part.  
Generally, mechanical biosensors take advantage of the development of nanofabrication 
that the physical size of the mechanical part scales down to micro- or nano-range. First, the 
detection limit of added mass is proportional to the total mass of the device. 
Nanoelectromechanical system (NEMS) have achieved zeptogram-scale mass resolution 
when operating in vacuum [23], and nanogram resolution when operating in a fluid 
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environment [24].  Second, the mechanical compliance of a device – its ability to be 
displaced or deformed – greatly increases with uniform reduction of its dimensions. Third, 
with the scaling down of device size, the fluidic mechanical devices can exhibit fast 
response time. This allows the biological reactions to be observed more detailed with high 
time-resolution. 
 
Figure 1.3 Surface-stress mechanical biosensors. Binding of target molecules generates 
surface stress, which makes the microcantilever deflect [25]. 
Surface-stress Mechanical Biosensors 
        In the mechanical biosensors, a small cantilever is usually a central part which is 
sensitive to the biomolecules of interest. Surface-stress mechanical biosensors measure the 
quasistatic deflection of a cantilever, caused by the biomolecules binding to the surface 
immobilized functional groups (Figure 1.3). When binding happens, surface stress is 
developed – owing to electrostatic attraction or repulsion, steric interactions, hydration and 
entropic effects. And the stress causes deflection of the mechanical element which can be 
measured by reflecting a laser beam off the cantilever. It has been reported the study of 
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DNA hybridization [26], binding of mRNA [27], and drug interaction [28] by measuring 
the surface stress change with cantilever. Reported sensitivities range from ~100 pM to 
few nM range. The limitation of this method is it cannot offer real-time information 
because what measures is the surface stress induced quasistatic deformation of the 
cantilever.  
 
Figure 1.4 Illustration of two mass measurement modes enabled by a fluidfilled 
microcantilever. a, A suspended microcantilever transduces mass change to resonant 
frequency shift. Fluid continuous flows through the cantilever and transport biomolecules, 
cells, and nanoparticles passing through the channel. By scaling down the wall and fluid 
layer thickness to micrometer size and packaging it in the high vacuum, the microcantilever 
attained mass sensitivity of sub-fetomgram. b, While bound and unbound molecules both 
increase the mass of the channel, species that bind to the channel wall accumulate inside 
the device, and, as a result, their number can greatly exceed the number of free molecules 
in solution. This can be used for the real-time monitoring specific capture events happening 
in the channel. c, In another measurement mode, cells or nanoparticles are flowing through 
the channel without any binding to the surface, the observed signal is dependent on the 
position of cells or particles along the channel (insets 1-3). The cells or nanoparticles mass 
can be measured by the resonant frequency shift [29]. 
12 
 
Dynamic-mode Mechanical Biosensors 
        These devices are not measuring the quasistatic deflection. They are oscillating with 
a resonant frequency and when the biomolecules of interest target on the cantilever, the 
resonant frequency shifts. Continuous operation allows continuous monitoring and fast 
detection molecular interaction. With the dynamic-mode mechanical biosensors immersed 
in the fluid, the detection limit goes to picomolar and the response time is a few minutes. 
Since it is a mass change based frequency shift method, the concentration sensitivity highly 
depends on analyte molecular weight. Subpicomolar sensitivity of  detection bacterial virus 
T5 (molecular weight = 7×107 Da) was reported [24].For smaller peptides like ferrichrome 
(molecular weight = 687.7 Da), the sensitivity is typically micromolar. When the system 
has a high quality factor, Q, it is very sensitive in the frequency-shift based mass detection. 
However, for the continuous monitoring, the cantilever is immersed in the fluid, the quality 
factor, Q is susceptible to the fluid such as the damping which diminishes the Q and results 
in the sensitivity decreasing. A very clever way to solve the sensitivity deterioration is to 
embed the microfluid channels with the mechanical cantilever rather than immersing the 
whole mechanical sensor in the fluid. Burg et al. fabricated such suspension microchannel 
resonators (SMRs) (Figure 1.4) with 15,000 quality factor to measure single cells and 
single nanoparticles in the fluid [29].   
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CHAPTER 2 
MEASURE KINETICS OF MOLECULAR INTERACTION BY REFLECTANCE 
INTERFEROMETRY 
2.1 Introduction 
        Molecular interactions play a crucial and complicated role in biological systems. As 
a living biological system, all the components are interacting with each other via molecular 
interactions, and physiological function and disease progression are also relied on 
molecular interactions. To study these interactions is important for understanding 
biological activities, discovering biomarkers, and screening drugs. A lot of efforts have 
been made to study and measure these interactions. The further understandings on 
biomolecular interactions increases the need for high-throughput, sensitive, fast, and 
economic way to study them.  
        Graphene with several nanometers and even sub-nm thickness was imaged by optical 
microscope [30]. And based on this interference method, different thickness of graphite 
layers can be distinguished [31, 32]. This straightforward optical method can be applied to 
the biological study for detecting molecular interactions. The bound molecule changes the 
optical path length which results in interference phase change. Silicon is widely used in 
semiconductor industry and is easy to manufacture and process. The silicon based 
biosensor for molecular interaction is low cost.  
        In this chapter, the first part is to describe the biosensor, which is based on the fact 
that bound molecule increases the optical pathway and therefore shifts the interference 
phase as well as changes the reflectance. Second part is the real-time detection of IgG and 
anti-IgG interaction by this method.  By fitting the data with the first order kinetics, the 
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association rate constant (kon), dissociation rate constant (koff), and dissociation constant 
(KD) were found to be kon = 1.43 × 104 𝑀−1𝑠−1 , koff = 1.47 × 10−3 𝑠−1  and KD = 
95.8 𝑛𝑀. These results are in good agreement with those obtained with plasmonic method. 
Last part is the improvement in image quality by pixel-to-pixel correction for the future 
microarray application.  
2.2 Principle of Reflectance Interferometry Based Biosensor 
        The detection method is based on reflectance interferometry. Briefly, the optical path 
change introduced by the bound protein was measured. A 300 nm SiO2 layer on top of 
silicon was used as the sensor surface. The binding process was monitored by a webcam 
with R, G, and B three channels.  
 
Figure 2. 1 Principle of the reflectance interferometry based biosensor. (A) The surface 
is vertically illuminated with white light, and the reflected light is imaged by a webcam. 
The additional height of the surface will change the optical path difference between the top 
surface and buried oxide-silicon surface which will change the reflected light. (B) Paths of 
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light rays in multiple reflection between two surfaces – top surface and buried oxide-silicon 
surface. 
        Figure 2.1A shows the geometry we used in the experiment. Let r be the coefficient 
of reflection and t the transmission coefficient. Then provided there is no absorption in 
protein, silicon dioxide and silicon, the amplitudes of the successive internally reflected 
rays are 𝐸0𝑡1, 𝐸0𝑡1𝑟2, 𝐸0𝑡1𝑟2(−𝑟1), 𝐸0𝑡1𝑟2
2(−𝑟1), 𝐸0𝑡1𝑟2
2(−𝑟1)
2, 𝐸0𝑡1𝑟2
3(−𝑟1)
2, … , as 
indicated in Figure 2.1B, where 𝐸0 is the amplitude of the primary ray, 𝑡1, 𝑟1, 𝑟2 are the 
transmission coefficient at air/solution-SiO2 interface, reflection coefficient at air/solution-
SiO2 interface and SiO2-Si interface respectively. Consequently, the sequence 
𝐸0𝑟1, 𝐸0𝑡1
2𝑟2,  𝐸0𝑡1
2𝑟2
2(−𝑟1),  𝐸0𝑡1
2𝑟2
3(−𝑟1)
2 , … , represents the amplitudes of the 
reflected rays. It is obviously shown that the geometric path difference between two 
adjacent rays coming out from top surface is 
∆= 2𝑑 𝑐𝑜𝑠𝜃                                                       (2.1) 
where d is the thickness of SiO2 layer and 𝜃  is the angle between any two internally 
reflected ray and the surface normal as indicated in Figure 2.1B. The phase difference 
between any two successive rays is given by 
∅ = 2𝑘𝑑 𝑐𝑜𝑠𝜃 =  
4𝜋
𝜆0
𝑛1𝑑 𝑐𝑜𝑠𝜃                                      (2.2) 
where 𝑛1 is the refractive index of SiO2, 𝜆0 is the vacuum wavelength. Taking the phase 
difference into account as a factor 𝑒−𝑖∅ and summing the amplitude of the rays coming out 
from top surface, we obtain 
𝐸𝑟 = 𝐸0𝑟1 + 𝐸0𝑡1
2𝑟2𝑒
−𝑖∅ + 𝐸0𝑡1
2𝑟2
2(−𝑟1)𝑒
−𝑖2∅ + 𝐸0𝑡1
2𝑟2
3(−𝑟1)
2𝑒−𝑖3∅ + ⋯           (2.3) 
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𝐸𝑟 = 𝐸0𝑟1 + 𝐸0𝑡1
2𝑟2𝑒
−𝑖∅ + 𝐸0𝑡1
2𝑟2𝑒
−𝑖∅(−𝑟1𝑟2𝑒
−𝑖∅) + 𝐸0𝑡1
2𝑟2𝑒
−𝑖∅(−𝑟1𝑟2𝑒
−𝑖∅)
2
+ ⋯       
(2.4) 
This is a geometric series with ratio −𝑟1𝑟2𝑒
−𝑖∅, and thus 
𝐸𝑟
𝐸0
= 𝑟1 + 
𝑡1
2𝑟2𝑒
−𝑖∅
1+𝑟1𝑟2𝑒−𝑖∅
= 
𝑟1+(𝑟1
2+𝑡1
2)𝑟2𝑒
−𝑖∅
1+𝑟1𝑟2𝑒−𝑖∅
= 
𝑟1+𝑟2𝑒
−𝑖∅
1+𝑟1𝑟2𝑒−𝑖∅
                     (2.5) 
with 𝑟1
2 + 𝑡1
2 = 1, provided SiO2 is lossless dielectric media. The reflectivity is then 
given by 
𝑅 =  
𝐼𝑟
𝐼0
= |𝑟|2 = 𝑟𝑟∗                                                (2.6) 
and thus for the geometry used in the experiment,  
𝑅 =  
(𝑟1+𝑟2𝑒
−𝑖∅)(𝑟1+𝑟2𝑒
𝑖∅)
(1+𝑟1𝑟2𝑒−𝑖∅)(1+𝑟1𝑟2𝑒𝑖∅)
=
𝑟1
2+𝑟2
2+2𝑟1𝑟2 𝑐𝑜𝑠∅
1+𝑟12𝑟22+2𝑟1𝑟2 𝑐𝑜𝑠∅
 .                        (2.7) 
The angle (𝜃) and the polarization dependence of the Fresnel reflection coefficients vanish 
for perpendicularly incident light (𝜃 = 0˚), hence 𝑟1, 𝑟2 and ∅ are given by 
𝑟1 =
𝑛0−𝑛1
𝑛0+𝑛1
                                                        (2.8) 
𝑟2 =
𝑛1−𝑛2
𝑛1+𝑛2
                                                        (2.9) 
∅ = 
4𝜋
𝜆0
𝑛1𝑑                                                    (2.10) 
where 𝑛0, 𝑛1, 𝑛2 are the refractive index of air/solution, SiO2 and silicon respectively. 
        According to Eqs. (2.7) to (2.10), the reflectance depends on the thickness of SiO2. 
To simplify the situation, we assume the protein accumulating on the surface have the same 
refractive index with SiO2, therefore, the binding of another protein is accompanied by the 
change of SiO2 thickness which results in the reflectance change. 
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2.3 Detection of Anti-IgG and IgG Interaction Based on Reflectance Interferometry  
2.3.1 Surface Modification and Channel Preparation 
        A silicon wafer with 300 nm thick SiO2 was used as the sensor surface. The silicon 
wafer was first cleaned with piranha solution (a mixture of 3:1 concentrated sulfuric acid 
to 30% hydrogen peroxide solution) and then dried with nitrogen. The cleaned silicon 
wafer was modified with amine group by soaking it into 50 mM 3-
Aminopropyletriethoxysilane (APTES) in toluene for 30 min. The silicon wafer was rinsed 
with toluene and acetone in succession and then dried with nitrogen. Amine modified wafer 
was stored in desiccator filled with nitrogen for use.  
 
Figure 2.2 Schematic drawing of the double-side tape formed flow channel. 
         A flow channel was created by the double-side tape. A slot with 3 mm in width and 
1 cm in length was cut by blade on the double-side tape as the flow channel. The double-
side tape was attached to the silicon wafer on one side and a glass coverslip was covered 
on the other side (Figure 2.2). The total volume of the channel can be controlled very small 
as the thickness of the double-side tape is only 50 μm. Solution flew over the channel due 
to capillary action. A piece of paper napkin positioned at one end of the channel to suck 
the solution with solution added at the other end of the channel made switch between 
different solutions.  
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        After modifying and making the channel, the wafer was positioned on an upright 
microscope (Olympus BX60) with a 4X objective and perpendicularly illuminated with a 
white light from top. The reflected light was imaged and recorded by the webcam with the 
frame rate of 15 fps. 
2.3.2 IgG Online Modification  
        To demonstrate molecular interaction detection capability with the present method, 
we studied the binding of anti-human IgG with human IgG (To simplify, in the later content, 
IgG and anti-IgG mean human IgG and anti-human IgG if not mention specifically). The 
silicon wafer was modified with amine group and a flow channel was formed as described 
above. IgG was on-line modified on the silicon wafer and monitored by this method (Figure 
2.3). First the channel was filled with 1X PBS buffer and then solution was switched to 
100 μg/ml IgG (in 1X PBS) with 50 mg/ml bis(sulfosucinimidyl)suberate (BS3). Upon the 
switch, the intensity in R component decreased rapidly (blue block in Figure 2.3 B). After 
1X PBS was changed back, the intensity still remained the same, which showed the IgG 
was modified on the silicon wafer surface. IgG and BS3 was in 1X PBS buffer with 5% 
DMSO. In order to confirm the decrease in intensity was not due to the refractive index 
change introduced by DMSO, we switched 1X PBS to 5% DMSO in 1X PBS (gray block 
in Figure 2.3B). There was only small increase in intensity which excluded the possibility 
that the decrease in intensity was due to refractive index difference between two solutions.  
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Figure 2.3 Online modification of IgG on surface. (A) One snapshot of channel taken 
by webcam. Three black boxes marked the regions for the intensity plot in (B). Intensity 
of R component in three different regions within the channel was plotted. (B) 1X PBS was 
flowing initially and then was switched to 100 μg/ml IgG with 50 mg/ml BS3 (blue block). 
Intensity in R component decreased because of IgG binding on the surface. The solution 
was switched back to 1X PBS at 600 s (white block). The intensity stayed the same which 
suggested IgG was covalently bound on the surface. 5% DMSO in 1X PBS was flowing to 
exclude the possibility that the decrease in intensity was due to refractive index change 
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introduced by DMSO (gray block). A sudden increase when 5% DMSO was flowing over 
the surface which was due to the refractive index change. When the solution was changed 
back to 1X PBS, the intensity went back to stable.  
2.3.3 Anti-IgG and IgG Interaction 
        After IgG was modified on the sensor surface, 1X PBS buffer was switched to 100 
μg/ml anti-IgG. Figure 2.4A shows upon the switch, the intensity in R component 
decreased in the association phase and then stayed stable. When the solution was changed 
back to 1X PBS, the intensity went back a little due to the dissociation process. The surface 
was then regenerated by 10 mM HCl. After regeneration, 100 μg/ml BSA was flowing over 
the surface as a negative control to confirm the signal was due to the specific interaction 
between anti-IgG and IgG. No obvious change in intensity was observed when the solution 
was changed to BSA. The regeneration by 10 mM HCl was followed by the negative 
control. 100 μg/ml anti-IgG was flowing over the regenerated sensor surface for the second 
time. Similar amount of decreasing in intensity of R component was shown in the 
association phase and some anti-IgG dissociated from the surface when solution was 
changed to 1X PBS. The similar responses of the anti-IgG and IgG interaction before and 
after regenerating of sensor surface demonstrated that the regeneration did work and also 
the response was due to the specific binding between anti-IgG and IgG interaction. Figure 
2.4B shows the experimental data (black dots) and fitted result with first order kinetics (red 
line) of anti-IgG and IgG interaction. From the fitting, the association rate constant (kon), 
dissociation rate constant (koff), and dissociation constant (KD) were found to be kon = 
1.43 × 104 𝑀−1𝑠−1, koff = 1.47 × 10−3 𝑠−1 and KD = 95.8 𝑛𝑀. These results are in good 
agreement of that measured by plasmonic method [33]. 
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Figure 2.4 Anti-IgG and IgG interactions. (A) The intensity plots of R component within 
three regions marked in Figure 2.3A. During the time marked by red blocks, 100 μg/ml 
anti-IgG was flowing over the surface. 1X PBS was flowing over the surface within the 
time marked by white blocks. And the surface was regenerated by 10 mM HCl in the 
periods of time marked by blue blocks. (B) Sensorgram of anti-IgG and IgG interaction. 
The experimental data (black dots) was fitted with first order kinetics (red line). From the 
fitting, the association rate constant (kon), dissociation rate constant (koff), and dissociation 
constant (KD) were found to be kon = 1.43 × 104 𝑀−1𝑠−1, koff = 1.47 × 10−3 𝑠−1 and KD 
= 95.8 𝑛𝑀. These results are in good agreement of that measured by plasmonic method 
[33]. (C) Intensity of R, G and B components within region 2 marked in Figure 2.3A when 
anti-IgG interacted with IgG. Red block marks the time period when 100 μg/ml anti-IgG 
flew over the surface. White blocks represent the time block during which 1X PBS was 
flowing.  
        The intensity changes of R, G and B components for the anti-IgG and IgG interaction 
are shown in Figure 2.4C. R component shows obvious signal of anti-IgG and IgG 
association and dissociation, while no detectable changes is shown in G component and 
only smaller signal shown in B component compared to R component. Also for the B 
component, the signal noise ratio is obviously smaller than that of R component. Red light 
is more sensitive to protein thickness change by reflectance interferometry. 
2.4 Image Correction for Protein Spot Recognition 
        Imagers are increasingly widely used in modern sciences and technologies. Images or 
a sequence of images (e.g. videos) also gain much broader scopes because of the growing 
importance of scientific visualization, which provides direct perception and high content 
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of big data. A variety of fields, including DNA microarray in genomics [34], super-
resolution microscopy [35], single nanoparticle catalytic reactions mapping [36] and etc., 
are all relied on the imagers. The noise level of the imager highly affects the interpretation 
of scientific data. In 2-D images, the artifacts caused by variations in the pixel-to-pixel 
light sensitivity and the dark currents of the imager distort or blur the original patterns, 
which makes the pattern recognition difficult and detection unreliable. A technique called 
flat-field correction was invented to compensate the different pixel sensitivities and dark 
current in the detector [37]. Seibert et al. constructed a flat-field image by acquiring 
multiple images under a uniform illumination over a range of incident exposures [38]. In 
order to extend the application of reflectance interferometry to high-throughput detection, 
microarray should be employed. And in order to achieve this goal, we first need to clearly 
recognize protein arrays. Here we use similar flat-field correction method to obtain a 
reliable and accurate flat-field correction on both CCD camera and webcam. After 
correction, the unfavorable pattern due to the artifacts were removed and the intensity 
variation in space was also reduced by at least two times. The protein spot was clearly 
recognized. 
2.4.1 Calibration Method and Result 
        The calibration is based on the fact that the imager is a linear system to the incident 
exposures within the dynamic range. The variable pixel gains and dark currents of the 
camera are corrected at the same time, pixel by pixel. A number of images were taken 
under uniform illumination over different incident intensities (Figure 2.5B). The exposure 
time of the camera was set the same. The acquired images show uneven intensity over the 
view due to pixel-to-pixel variations in sensitivity and dark current. The average intensity 
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over the whole image was set as the “real intensity” for certain incident intensity. For each 
pixel, the measured intensity is linearly proportional to the “real intensity” as the camera 
is a linear digital system (Figure 2.5C). And thus by linearly fitting the measured intensity 
in the function of “real intensity”, the fitting parameters, slope k and intercept b are 
obtained, which corresponds to the sensitivity and dark current for certain pixel 
respectively. The relation is shown as 
𝐼𝑖𝑗
𝑀 = 𝑘𝑖𝑗𝐼
𝑅 + 𝑏𝑖𝑗,                                                 (2.11) 
where 𝐼𝑖𝑗
𝑀, 𝑘𝑖𝑗, and 𝑏𝑖𝑗 are the measured intensity, slope and intercept for the pixel in 𝑖
𝑡ℎ 
row 𝑗𝑡ℎ  column respectively and 𝐼𝑅  is the “real intensity” for certain illumination. By 
doing the linear fitting for each pixel, the sensitivity correction matrix 𝐾 and dark current 
correction matrix 𝐵 are obtained. For a given raw image (𝐼𝑟𝑎𝑤)which is taken with the 
same camera exposure time as that of uniform illumination image, the corrected image 
(𝐼𝑐𝑜𝑟𝑟𝑒𝑐𝑡) is obtained by  
𝐼𝑐𝑜𝑟𝑟𝑒𝑐𝑡 = (𝐼𝑟𝑎𝑤 − 𝐵)/𝐾,                                        (2.12) 
where 𝐵  and 𝐾  are the dark current and sensitivity correction matrices respectively. 
Comparing to the conventional flat-field correction method which only acquires one flat 
field image and one dark image [37], this method suppresses random noises by taking 
multiple images and statistic fitting. 
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Figure 2.5 Procedure of calibration method. (A) Flow diagram shows the calibration 
method. (B) A sequence of images with different illumination intensities. (C) The relation 
between measured intensity and “real intensity” of R component for different pixels.  
2.4.2 Image Correction with Protein Spot 
        To demonstrate the feasibility of the correction method, a clean silicon wafer with 300 
nm SiO2 was imaged by a webcam under an upright microscope with a 4X objective. The 
illumination light intensity was adjusted and seven images were obtained at different 
incident light intensities for obtaining the correction matrices (Figure 2.5B). Figure 2.5C 
plots the measured intensity of three different pixels vs the real intensity which is the 
average intensity of the whole image. It is shown a good linear relation between the 
measured intensity and the real intensity. The slope and intercept which represent the 
sensitivity and dark current respectively were obtained by the linear fitting. The sensitivity 
and dark current correction matrices were formed by repeating the fitting pixel by pixel 
(Figure 2.6). The sensitivity of each pixels are similar with only ± 6% variations (Figure 
2.6A), while the dark current of each pixels varies a lot (Figure 2.6B). Figure 2.6 also 
shows that there is similarity in the pattern of sensitivity map and that of offset map, 
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however two patterns are not completely overlapped. The sensitivity and dark current are 
not necessarily correlated. 
 
Figure 2.6 Slope map (A) and offset map (B) obtained by the method described above for 
the sequence of images in Figure 2.5B. 
        A drop of 1 mg/ml BSA solution (in 1X PBS) with 50 mg/ml 
bis(sulfosucinimidyl)suberate (BS3) was dripped on the amine modified silicon wafer 
(modification see section 2.3.1) for 10 min. The silicon wafer was rinsed with DI water 
with water flowing from one direction. Then the silicon wafer was dried with nitrogen and 
imaged with an upright microscope (Olympus BX60) with a 4X objective. The red 
component of the raw image is shown in Figure 2.7A. The artificial pattern which shows 
dimmer in center while brighter at the edge makes the protein droplet difficult to recognize. 
After correcting the red component of the raw image by the correction matrices according 
to Eq. (2.12), very clear boundary between the silicon wafer background and protein 
droplet is shown in Figure 2.7D. Figure 2.7D also shows obvious difference between the 
silicon wafer (left) and the protein droplet (right). An extra layer of protein layer on top of 
silicon wafer reduces the reflection of red light because of the additional optical path length 
according to Eq. (2.7). Figures 2.7 B and E show the intensity along the black lines in 
Figures 2.7 A and D respectively. The global variation was removed and the intensity 
27 
 
difference between the silicon wafer and protein layer is larger after correction. Figures 2.7 
C and F are the zoom in plots of the red portions in Figure 2.7 B and E respectively. The 
standard deviation over the 70 pixels in Figure 2.7C was 0.482 while it was only 0.232 in 
Figure 2.7E. The variation in pixel-to-pixel intensity was also reduced at least 2 times by 
the flat-field correction.  
 
Figure 2.7 Results of calibrated webcam image with protein on silicon wafer. (A) R 
component of raw image. (B) Intensity plot along the black line in (A). (C) Zoom in of the 
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region marked by red block in B. (D) Calibrated image of (A). (E) Intensity plot along the 
black line in (D). (F) Zoom in of the region marked by red block in (E). 
        To demonstrate that the correction matrices are stable, a raw image (Figure 2.8A) was 
taken 2 hours after taking the uniform illumination images. Using the correction matrices 
obtained 2 hours ago, the corrected image (Figure 2.8B) shows similar quality compared 
to Figure 2.7D. 
 
Figure 2.8 Result of calibrated webcam image which was taken 2 hours after taking 
the uniform illumination images. (A) R component of the raw image. (B) Calibrated 
image of raw image in (A). 
        This flat-field correction method can also be used for CMOS research camera. A 
CMOS research camera (Pike Guppy) was used to take image of a clean silicon wafer under 
the upright microscope with a 4X objective. The black dots in Figure 2.9A came from the 
dirt in the optical path or on the camera. Figure 2.9A also shows non-uniformity in intensity 
that center is brighter than the corners. After correction, all these artifacts were removed 
and the image became very uniform (Figure 2.9B). Figure 2.9C shows the intensity plots 
(red lines) along the white lines in Figures 2.9 A and B. the intensity of pixel-pixel variation 
was reduced by 30 times after correction compared to the raw image (black line in Figure 
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2.9 C). With the same correction matrices, a raw image of silicon wafer half covered with 
protein layer was taken by the CMOS camera (Figure 2.9D). The ghost dots were still in 
the image because of the same camera and optical path. It is obvious that after correction, 
the image became more uniform and the difference between silicon wafer and the part with 
protein layer was more pronounced. This CMOS camera is monochromic and the silicon 
wafer was illuminated by the white light. A layer of protein on the silicon wafer generally 
reduced the reflection of white light. The line profiles in Figure 2.9F clearly show the big 
improvement in pixel-pixel intensity variation as well as overall non-uniformity reducing 
due to the correction. A pronounced step in intensity at the boundary between silicon 
background and protein layer is shown in the line profile after flat-field correction (red line 
in Figure 2.9E). 
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Figure 2.9 Results of calibrated CMOS research camera images. (A) Normalized raw 
image of a clear silicon surface. (B) Corrected image of (A). (C) Normalized intensity plots 
along the white lines in (A) (black) and (B) (red). (D) Normalized raw image with protein 
on silicon wafer (right half). (E) Corrected image of (D). (F) Normalized intensity plots 
along the white lines in (D) (black) and (E) (red). 
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2.5 Conclusion 
        In this chapter, we have shown the successful kinetics measurement of anti-IgG and 
IgG by the reflectance interferometry. This method is simple and based on silicon wafer 
which is widely used in semiconductor industry and thus is low cost. We have also shown 
the flat-field correction with each pixels removes both image’s overall non-uniformity and 
artifacts due to dirt in optical pathway. This method also reduces the pixel-to-pixel 
variations to obtain 30 times lower spatial noise level than that before correction. This 
method is applied to all type of cameras from webcams to high quality research cameras. 
With this method, a thin layer of proteins on silicon wafer was obviously detected. The 
correction benefits pattern recognition, objective tracking and can be used for the future 
microarray measurement of reflectance interferometry. 
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CHAPTER 3 
DETECTION OF MOLECULAR BINDING VIA CHARGE-INDUCED 
MECHANICAL RESPONSE OF OPTICAL FIBER 
3.1 Introduction 
        High-throughput detection of molecular interactions is critical for understanding 
many biological processes, for detecting disease biomarkers, and for screening drug 
candidates [5]. To date the most widely used detection technique uses labels, such as 
fluorescence dyes. While popular and useful, the fluorescence-based approach can be 
problematic, especially when applied to the detection of small molecules, because the dye 
molecules can significantly alter the activities of small molecules, leading to inaccurate 
conclusions [8]. Various label-free techniques, such as surface plasmon resonance (SPR) 
technique [13, 39-41] and micro- and nanomechanical biosensors,[23, 29, 42, 43] and 
Quartz Crystal Microbalance [44] have been developed, but their sensitivities diminish 
with the size of the molecule [45]. Electrochemical impedance analysis [46-49] is also label 
free, but it detects interfacial capacitance or charge transfer taking place on an electrode 
surface, which is not universally applicable to the detection of different molecules, and its 
results are often difficult to quantify [50, 51]. A label-free method to detect small molecules 
still presents a technical challenge. On the other hand, small molecules are the most popular 
form of drugs, and play important roles in many biological processes [1], including post-
translational modification of proteins (e.g., phosphorylation), metabolism (e.g., ATP 
production and consumption), and cellular signaling processes (involving hormones, 
neurotransmitters and other small molecules). A capability of detecting small molecules 
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will have large impacts on the understanding of these processes, detecting of diseases, and 
discovery of drugs. 
        In this chapter, we report a new optical technique for detecting of both large and small 
molecules. The technique is based on that most molecules relevant to biomedical research 
and applications are charged or partially charged. Even if for neutral molecules, they are 
expected to alter the charge distribution on a sensor surface upon binding. The sensor is an 
optical fiber, which is dipped into the well of a microplate. It detects the surface charge of 
the fiber by converting the charge into an optical signal, which does not decrease with the 
size (mass) of the molecule, making it particularly attractive for studying small molecules, 
and biochemical interactions that involve small mass changes. In addition, it is compatible 
with the standard microplate technology for liquid sample handling, which promises high 
throughput screening and analysis. We describe below the working principle, experimental 
setup, validation of the working principle, detection of large and small molecules, as well 
as fundamental detection limit of the technique. 
3.2 Detection Principle and Experimental Methods 
3.2.1 Detection Principle 
        The basic principle of the detection technique is illustrated in Figure 3.1A, showing a 
single optical fiber or a bundle of individually detectable optical fibers dipped in a well of 
a standard 96, 384 or 1536-well microplate. An alternating electric field is applied in a 
direction perpendicular to the fiber. If charge is present on the fiber surface, each fiber will 
be driven into oscillation by the applied field. The oscillation amplitude is detected 
optically by tracking the tip position of the fiber using a differential optical detection 
method detailed later. To study molecular binding, the tip is functionalized with molecular 
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probes. Upon binding of a target molecule onto the molecular probes, the surface charge 
of the fiber changes, which is detected by monitoring the oscillation amplitude.  
        
 
Figure 3.1 Overview of CSOD. (A) Schematic illustration of CSOD setup. (B) A typical 
optical fiber with etched tip viewed from side. (C) Image of the fiber tip viewed from the 
bottom of the microplate well. (D) Differential optical detection for accurate determination 
of the fiber oscillation amplitude. (E) Fast Fourier transform (FFT) of the fiber oscillation. 
Inset: Oscillation displacement signal in time domain before FFT. The amplitude and 
frequency of the applied voltage were 1 V and 10 Hz, respectively. The length and diameter 
of the fiber were 8.5 mm, and 11 µm, respectively. The buffer was 40 times diluted 1X 
PBS. 
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         The key measurable parameter of the technique is the oscillation amplitude of the 
fiber tip, xs, at frequency ω, which is proportional to the effective surface charge density, 
σ, of the fiber, given by 
𝑥𝑠 =
2𝜋|𝐸(𝜔)⃗⃗⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗  ⃗|𝜎𝑟𝑙
√(𝑘𝑒𝑓𝑓−𝑚𝑒𝑓𝑓𝜔2)
2
+(𝑐𝜔)2
 ,                                            (3.1) 
where |E(ω)⃗⃗⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗   | is the electric field strength, c is the damping coefficient, and keff, meff, r and 
l are the effective spring constant, mass, radius and length of the optical fiber (Figure 3.1 
B), respectively. The fiber was usually etched to around 10 μm in diameter. The etched 
optical fiber probe is considered as a cylindrical shape. Figures 3.2 B and C show the distal 
and upper parts of the fiber. They are of similar diameter which supports the assumption 
that the etched fiber tip is a cylinder. The effective spring constant, 𝑘𝑒𝑓𝑓, of the cylindrical 
optical fiber probe is given by[52] 
                     k𝑒𝑓𝑓 = 
3𝜋𝐸𝑟4
4𝑙3
 ,                                                   (3.2)                                                               
where E, r and l are the Young’s modulus, radius and length of the optical fiber, 
respectively. 𝐸(𝜔)⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗   is generated by applying a voltage between two electrodes inserted in 
the solution of the well, which is frequency dependent and given by  
 |𝐸(𝜔)⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗ ⃗⃗  | = |𝐸0⃗⃗⃗⃗ |
𝑅𝑆
√𝑅𝑆
2+
1
(𝜔𝐶𝑒𝑓𝑓)
2
  ,                                       (3.3)  
where RS and Ceff are the solution resistance and effective interfacial capacitance 
respectively. In order to determine the resistance and effective capacitance, we measured 
the impedance (|𝑍(𝜔)|) at different frequencies. |𝑍(𝜔)|2 is given by 
         |𝑍(𝜔)|2 = 𝑅𝑆
2 +
1
(𝜔𝐶𝑒𝑓𝑓)
2   .                                        (3.4) 
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By fitting |𝑍(𝜔)|2 and frequency (𝜔), RS and Ceff can be extracted. Figure 3.3 shows the 
fitting of |𝑍(𝜔)|2 and frequency (𝜔), from which we obtain RS = 1.68 kΩ, and Ceff = 22.11 
µF. From Eqs. (3.1) and (3.3), the frequency at which the oscillation amplitude reaches 
maximum is at 
                                       𝜔𝑝 = √
𝑘𝑒𝑓𝑓
2
(𝐶𝑒𝑓𝑓
2𝑐2−2𝑘𝑒𝑓𝑓𝑚𝑒𝑓𝑓𝐶𝑒𝑓𝑓
2)𝑅𝑆
2+𝑚𝑒𝑓𝑓
2
4
  .                          (3.5) 
We measured the oscillation amplitude of fiber at different frequencies, from which we 
determined the maximum frequency, ωp. meff can be calculated from the diameter and 
length of the fiber, and c can be obtained from the frequency dependent amplitude. From 
the measured oscillation amplitude, xs, we can determine the surface charge density of the 
fiber according to Eq. (3.1), which allows us to monitor the binding of molecules onto the 
fiber surface. 
 
Figure 3.2  A typical optical fiber with etched tip viewed from side.  (a) Side view of the 
entire fiber. (b) Zoom in image of the upper part of the fiber. (c) Zoom in image of the 
lower part of the fiber. Scale bar: 20 µm. 
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Figure 3.3   |Z(ω)|2 vs. frequency, where the black dots are experimental data, and red line 
is a fit to Eq. (3.4).  
 
3.2.2 Differential Detection of Fiber Oscillation Amplitude 
        Accurate measurement of the oscillation amplitude is a key task in the present 
detection technique, which is achieved by a differential optical detection method that tracks 
the position of the optical fiber tip via optical imaging. The image of the tip from the bottom 
of the well, as obtained with an optical microscope, appears as a bright spot (Figure 3.1C). 
The differential optical detection method determines the oscillation amplitude of the optical 
fiber by dividing the bright spot into two regions, A and B, with a line perpendicular to the 
oscillation direction (Figure 3.1D). The division line is selected such that the intensities in 
regions A and B are similar initially, and (IA-IB)/(IA+IB) is monitored continuously with the 
camera, where IA and IB are the intensities of regions A and B, respectively. The 
displacement of the optical fiber was determined precisely from the differential optical 
detection method, which requires calibration. We calibrated the detection method using the 
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following procedure. A region of interest (ROI) including the image of the fiber tip was 
selected as shown in Figure 3.4A. The ROI was divided into A and B, marked by red and 
blue boxes, respectively, and then shifted vertically by different numbers of pixels to mimic 
the fiber movement (Figure 3.4A). One pixel was determined to be 0.74 µm from the 
optical system and physical size of CCD camera. The differential intensity at each position 
was determined from the image. Figure 3.4B plots the differential intensity vs. pixel 
position, which shows a linear relation and serves as a calibration curve. It has been shown 
that (IA-IB)/(IA+IB) is proportional to the oscillation amplitude of the fiber with a calibration 
factor determined experimentally.  
 
Figure 3.4 Calibration of oscillation amplitude. (A) Shifting ROI (red and blue boxes) to 
mimic fiber movement. From left to right, the ROI is shifted by -2, -1, 0, +1, +2 pixels, 
where “-” and “+“ indicates moving the ROI upward and downward, respectively. (B) 
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Relationship between differential intensity (IA-IB)/(IA+IB) and fiber movement (shifting of 
ROI), where the red line is a linear fit to the experimental data (black square).  
        This detection method is accurate because it rejects common noises in regions, A and 
B. It is clear that the sharper the fiber tip, the more sensitive the detection of the oscillation 
amplitude. For this reason, the fiber tip is etched into a sharp point to create a small bright 
spot in the image. With the differential optical detection principle we have determined the 
displacement of a fiber in response to an applied electric field. The inset of Figure 3.1E 
shows the oscillation of a fiber driven by a sinusoidal potential with frequency 10 Hz and 
amplitude 2 V. In addition to the use of the differential optical detection method, Fast 
Fourier Transform (FFT) filter is used to further remove noises at frequencies different 
from that of the applied electric field. Figure 3.1E is the FFT of the time domain data 
plotted in the inset of Figure 3.1E, which shows a sharp peak. From the peak height in the 
FFT spectrum, we determine the oscillation amplitude of the fiber. Using the combined 
differential detection method and FFT filter, we achieved a detection limit of 0.25 nm for 
the oscillation amplitude, corresponding to an effective charge detection limit of ~0.25 
electron charge/µm2. We will return to the discussion of detection limit later. Note that 
peak quality in the FFT spectrum increases with time duration, and we used a typical time 
duration of 1 second, which is fast enough for most molecular binding processes. 
3.2.3 Materials and Methods 
        Preparation of optical fiber probes: A 125 µm diameter optical fiber from Thorlabs, 
Inc. was first soaked in acetone for 1 minute, then rinsed with deionized (DI) water, and 
finally dried out with N2. The polymer coating of the fiber was stripped off to expose the 
glass surface of the fiber with an optical fiber stripping tool. The bare optical fiber was 
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dipped in 47% Fluoric Acid (HF) for 30 minute, which etched the fiber down to ~12 µm 
in diameter. The etched fiber was thoroughly rinsed with DI water and then dried out with 
N2. To minimize surface contamination, the fiber was stored in a desiccator filled with N2 
before using it.  
        The electric field was created with a two-electrode setup. A sinusoidal voltage wave 
generated by a function generator was applied between the two electrodes via a potentiostat 
(Pine, model AFCBP1). The applied voltage was controlled with a Matlab program. 
        Surface functionalization of optical fibers: The etched fiber was first modified with 
APTES ((3-Aminopropyl)triethoxysilane) to allow crosslinking of APTES to the probe 
molecules. Before surface functionalization, each etched optical fiber was cleaned with 
oxygen plasma for 3 minutes. The surface functionalization of the fiber took place in a 
desiccator, which was first purged with argon for 3 minutes before adding 30 µl of APTES 
and N,N-Diisopropylethylamine each into two small containers placed inside the 
desiccator. The desiccator was purged with argon for 3 more minutes and then sealed to 
allow surface reaction overnight. After the surface functionalization procedure, the optical 
fiber was placed in an oven heated to 110 °C for 30 minutes before each experiment.  
        For the detection of BSA, the amine-coated optical fiber was incubated in NHS-Biotin 
(N-hydroxysuccinimidobiotin) solution for 1 hour. The NHS-Biotin solution was prepared 
by dissolving 0.2 mg NHS-Biotin in 59 µl DMSO (dimethyl sulfoxide) and then adding it 
to 1.5 ml of PBS. After incubation, the fiber was rinsed with DI water and dried out with 
N2 before experiment. For the detection of imatinib, kinase c-Abl (or c Kit or myelin basic 
protein) was immobilized on the fiber with 1, 5-Glutaraldehyde by incubating amine-
coated fiber in 2.5% 1, 5-Glutaraldehyde for 40 minutes. The fiber was rinsed with DI 
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water and then placed in the 0.8 µg/ml c-Abl solution (or 25 µg/ml c-Kit protein solution 
or 25 µg/ml myelin basic protein solution) immediately for 1 hour. The c-Abl (or c-Kit or 
myelin basic protein) modified fiber was rinsed with 1X PBS. 
        Experimental setup: An inverted optical microscope (Olympus IX70 with 40x 
objective) was used for the differential optical detection method. A 96-well microplate was 
placed on the microscope stage. Each optical fiber was placed between two platinum 
electrodes (1 cm × 0.5 cm) separated with a distance of 3 mm, and the assembly was 
mounted on a manipulator so that it could be moved in and out of the wells of the microplate 
easily. A CCD camera controlled by a homemade Matlab program was used to record the 
image of the optical fiber tip. 
        Data processing: The oscillation amplitude of the fiber was monitored by the CCD 
camera at 247 frames per second with the differential optical detection method. The 
relationship between the oscillation amplitude and the measured differential intensity from 
the differential optical detection method was determined before each experiment with the 
following method. The distance for one pixel of the image was known to be 0.74 µm from 
the optical system and CCD camera. The region of interest (ROI) containing the image of 
the fiber tip was shifted by different numbers of the pixels manually, and the corresponding 
changes in the differential intensity were determined from the images. The relationship 
between the differential intensity and the fiber movement (pixels) was found to be linear, 
from which the calibration factor of the differential detection method was determined 
(section 3.3.2). 
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3.4 Results 
3.4.1 Validation of Detection Principle 
        In order to validate the working principle, it is essential to examine the predictions of 
Eq. (3.1). According to Eq. (3.1), the oscillation amplitude of the optical fiber is 
proportional to the applied electric field. To verify this, we measured the oscillation 
amplitude vs. applied voltage (Note: The voltage is proportional to the electric field.). The 
result is plotted in Figure 3.5A, which shows that the oscillation amplitude is indeed 
proportional to the applied field, as predicted by Eq. (3.1). 
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Figure 3.5 Theory validation of CSOD. (A) Fiber oscillation amplitude vs. applied voltage 
at 40 Hz, where the square dots are the experiment data, and the red line is the linear fit. 
Fiber diameter: 8 µm, length: 7.5 mm. (B) The oscillation amplitude (top panel) and phase 
(bottom panel) of an amine-modified fiber recorded during the change of the solution from 
low to high pH values. Fiber diameter: 20 µm, length: 10 mm. (C) Fiber oscillation 
amplitude vs. frequency, where the black dots are experimental data and the red line is the 
prediction of Eq. 1. Fiber diameter: 11 µm, length: 8.5 mm. 
        Equation (3.1) also predicts that the oscillation amplitude is proportional to the surface 
charge density, and the oscillation phase changes by 180 degrees when the charge changes 
polarity. To validate these predictions, we coated the fiber surface with amine-terminated 
silanes. The amine group has a pKa value between 10-11. When pH << 7, the amine group 
is protonated, resulting in a positive surface charge. In contrast, when pH >> 7, the amine 
group is neutral, but since the background silica is negatively charged, the surface is 
negatively charged. We measured the oscillation amplitude and phase in 0.5 mM H2SO4, 
then replaced the acidic solution with 1 mM NaOH. In 0.5 mM H2SO4, the phase shift is 
close to 0 degree, indicating that the oscillation is in phase with the applied electric field, 
which is consistent with the positively charged fiber surface (top panel, Figure 3.5B). After 
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replacing acidic solution with 1 mM NaOH, the amplitude decreases because of the de-
protonation of the amine group, resulting in a decrease in the surface charge. When the 
amplitude decreases to zero, the phase changes by 180 degrees, indicating the change in 
the charge polarity (bottom panel, Figure 3.5B). The amplitude then increases as the 
surface becomes more and more negatively charged. 
         Another important prediction of Eq. (3.1) is the characteristic frequency-dependence 
of the oscillation amplitude. Figure 3.5C plots a typical frequency response of the 
oscillation amplitude, which shows a broad peak near 10 Hz. The frequency response can 
be fitted with Eq. (3.1) (red line) with calculated keff = 7.6×10
-4 N/m, meff = 1.8 ng and 
fitting parameter c = 7.5×10-6 N∙s/m, and the frequency dependent electric field. As 
indicated by the broad peak in Figure 3.5C and the parameters above, the oscillation is 
heavily damped, so that the amplitude is insensitive to mass changes associated with 
molecular binding. 
3.4.2 Detection of Large Molecules 
        To demonstrate the detection of large molecules, we modified the fiber surface with 
streptavidin and studied the binding of biotinylated BSA to streptavidin (Figure 3.6A). 
Initially, we dipped the fiber into a microplate well filled with 350 µl of PBS buffer, and 
drove it into oscillation with an applied electric field. We then injected 10 µl of buffer 
(black arrow) into the well as a control, and observed no detectable changes in the 
oscillation amplitude, indicating that the injection of solution did not introduce significant 
mechanical perturbation. We then added 10 µl of 250 µg/ml biotinylated BSA (red arrow) 
into the microplate well, and found that the amplitude increased and then reached a stable 
level. The increase in the oscillation amplitude is expected because of the following 
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considerations. The isoelectric point (pI) of streptavidin is 5-6 [53], so the streptavidin-
coated fiber was negatively charged in PBS buffer, which was confirmed from the phase 
of the oscillation. BSA was also negatively charged in the buffer because its pI is around 5 
[54], therefore, the binding of biotinylated BSA onto streptavidin added more negative 
charges onto the fiber surface, causing an increase in the oscillation amplitude. 
        We further studied the binding of anti-BSA onto the BSA-coated fiber by adding 10 
µl of 0.5 µg/ml anti-BSA into the well, which led to a final concentration of 0.2 nM anti-
BSA. Figure 3.6B shows that the amplitude increased initially and then reached a stable 
value. This observation is consistent with that anti-BSA with a pI between 5.2-6.0 [55] is 
also negatively charged in the PBS buffer. Note that before adding anti-BSA into the well, 
10 µl of buffer solution was added, and the change of amplitude was within the noise level, 
which again rules out the possibility that the observed oscillation amplitude change was 
due to mechanical perturbation by the introduction of the sample solutions. 
 
Figure 3.6 Protein detection by CSOD. (A) Biotinylated BSA binding onto streptavidin-
coated fiber. The black arrow marks the addition of 10 µl buffer and the red arrow marks 
the addition of 10 µl 250 µg/ml biotinylated BSA (resulting in a final concentration of 100 
nM biotinylated BSA). Fiber diameter: 11 µm, length: 7 mm. Buffer: 40 times diluted 1X 
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PBS buffer. (B) Anti-BSA binding onto BSA-modified fiber surface. The black arrow 
marks the addition of 10 µl buffer, and the red arrow marks the addition of 10 µl 0.5 µg/ml 
anti-BSA leading to a final concentration of 0.2 nM. Fiber diameter: 18 µm, length: 7.5 
mm. Buffer: 40 times diluted 1X PBS buffer. 
3.4.3 Detection of Small Molecules 
        To demonstrate the small molecule detection capability of the present detection 
technique, we studied the binding of imatinib to c-Abl (Figure 3.7A). c-Abl is a nonreceptor 
tyrosine kinase linked to the growth factor receptor signaling in human[56], and imatinib 
is an anticancer drug that inhibits the enzyme activity of c-Abl via binding to the ATP site 
of the protein[57]. The molecular weight of imatinib is 493 Da, which is difficult to detect 
by traditional label-free detection methods, especially when the surface coverage of c-Abl 
is low.  
        The optical fiber coated with c-Abl was first dipped into a microplate well containing 
350 µl of 2.5 mM Tris-HCl buffer (pH=7.5) and 1 mM MgCl2. Then 10 µl of the same 
buffer was injected into the well, and followed by repeated additions of 10 µl of 510 µM 
imatinib in 2.5 mM Tris-HCl buffer (pH=7.5) with 1 mM MgCl2. Each addition 
corresponded to a 15 µM increase in the imatinib concentration. Similar to the finding 
described above, the addition of pure buffer resulted in no detectable changes in the 
amplitude of the optical fiber. In contrast, upon the first addition of imatinib (red arrow), 
the amplitude decreased sharply, and then reached a stable level. The decrease in the 
amplitude is expected because imatinib is positively charged. The second addition of 
imatinib produced a smaller decrease in the amplitude, due to the depletion of the c-Abl 
binding sites for imatinib. The solution in the well was changed back to the buffer (blue 
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arrow), which led to recovery in the amplitude due to the dissociation of imatinib. The 
phase shift between oscillation and electric field (Figure 3.7B) remained constant during 
the binding process, indicating no change in the charge polarity during the measurement. 
 
Figure 3.7 Small molecule detection by CSOD. The oscillation amplitude (A) and phase 
shift (B) of a c-Abl-modified fiber during the binding of imatinib onto c-Abl. The black 
arrow marks the addition of 10 µl buffer, the red arrows mark the additions of 10 µl 500 
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µM imatinib (final concentration of 15 µM), and the blue arrow indicates the change of the 
solution back to buffer. Fiber diameter: 11 µm, length: 7 mm. (C) Negative control. Two 
successive additions of 10 µl 500 µM suberoylanilide hydroxamic acid (red arrows) to the 
c-Abl-modified fiber. Fiber diameter: 12 µm, length: 7.5 mm. (D) Negative control. 
Response of a fiber modified with myelin basic protein to the addition of 10 µl 500 µM 
imatinib (marked by a red arrow). Fiber diameter: 10.4 µm, length: 7 mm. (E) Inhibition 
of c-Abl with AMP-PNP (green arrows), exposure of the inhibited c-Abl to imatinib (red 
arrow), and replacement of the solution with PBS buffer (blue arrow). Red line is the 
average of the raw data (black line). Fiber diameter: 10 µm, length: 7.5 mm. (F) Positive 
control. The fiber was modified with c-kit kinase, which interacts with imatinib. Additions 
of 10 µl buffer and 10 µl 500 µM imatinib (final concentration: 15 µM), and change of the 
solution back to buffer are marked with black, red and blue arrows, respectively. Fiber 
diameter: 16 µm, length: 8 mm. Buffer for above experiments: 2.5 mM Tris-HCl buffer 
(pH = 7.5) with 1 mM MgCl2. 
        To further validate the observation above, we carried out several negative control 
experiments. The first negative control experiment was to expose a c-Abl coated optical 
fiber to suberoylanilide hydroxamic acid (SAHA). SAHA is a small molecule, and an 
inhibitor of pan-histone deacetylase, rather than c-Abl. The second negative control 
experiment was to coat an optical fiber with myelin basic protein, which does not bind to 
imatinib. In both cases, as shown in Figures 3.7 C and D, no changes in the oscillation 
amplitude were observed, which confirms that the observed changes in the oscillation 
amplitude in Figure 3.7A was due to the specific binding of imatinib to c-Abl, and non-
specific binding of imatinib onto the areas that were not covered with c-Abl is negligible. 
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        An additional control experiment was performed by first deactivating the binding sites 
of c-Abl with inhibitor, AMP-PNP, and followed by adding imatinib to the well. As shown 
in Figure 3.7E, upon the addition of AMP-PNP, the amplitude increased as AMP-PNP 
bound onto c-Abl and deactivated c-Abl. Note that the binding of AMP-PNP onto c-Abl 
caused an increase (green arrow), rather than a decrease in the amplitude as found in the 
case of imatinib. This is expected because AMP-PNP is negatively charged while imatinib 
is positively charged. Further addition of imatinib (red arrow) led to a small decrease in the 
amplitude. This control experiment provided extra evidence that the observed decrease in 
the amplitude shown in Figure 3.7A was due to specific binding of imatinib onto c-Abl. 
        Finally, we carried out a positive control experiment by immobilizing c-kit kinase. 
Like c-Abl, c-kit kinase can also be inhibited by imatinib[58]. Figure 3.7F shows the 
response of the oscillation amplitude of a c-kit kinase-coated optical fiber. Upon addition 
of 10 µl of 500 µM imatinib, the amplitude decreased as imatinib interacted with c-kit 
kinase, similar to the binding of imatinib onto c-Abl. This observation is consistent with 
the positive charge polarity of imatinib. 
3.5 Discussion 
3.5.1 Fundamental Detection Limit 
        The noise in the oscillation amplitude of the fiber is about 0.25 nm (averaged over 10 
s) as shown in Figure 3.8A. In terms of charge density, the detection limit is 0.25 
electrons/µm2. This detection limit is excellent compared to FETs, including conventional 
silicon-based, nanotube-based [59-61] or nanowire-based FETs [62-64], which are also 
sensitive to charge changes. For example, assuming that a 10 nm diameter and 1 µm length 
silicon nanowire FET reaches detection limit a single electron charge, the corresponding 
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surface charge density detection limit is ~32 electrons/µm2, 100 times less sensitive than 
that achieved with the present detection technique. In other words, FET can reach single 
electron detection limit in terms of total charge, but this detection limit is achieved at the 
expense of the effective detection area. The lowest analyte concentration that can be 
detected by a biosensor is determined by the number of detectable charges per unit area, 
rather than by the total detectable charges. 
        The detection limit of the present detection technique is determined by many factors, 
including the light source, optical detector (CCD imager), and mechanical noise of the 
setup. These noises have been reduced by carefully designing the experimental setup, and 
by using the differential optical detection and FFT filter techniques, but the ultimate 
detection limit is determined by the following fundamental factors. 
        Brownian motion: One of the factors that determine the fundamental detection limit 
is thermal fluctuations or Brownian motion of the fiber. Based on the damped harmonic 
oscillator model described by Eq. (3.1), the thermal fluctuations of the fiber amplitude will 
lead to thermal noises in the surface charge density and given by [65] 
𝜎𝑡ℎ𝑒𝑟𝑚𝑎𝑙 =
√2𝑘𝐵𝑇𝑐∆𝜔
2𝜋|?⃗? |𝑟𝑙
,                                            (3.6) 
where kB is the Boltzmann constant, T is temperature, ∆𝜔 is the bandwidth of 
detection. If integrating the signal over ~10 second, ∆𝜔 is about 0.2𝜋 , and the 
thermal noise limit on the detectable charge density is ~0.03 electron charges/𝜇m2 
for an optical fiber with r=10 µm and l=1 cm, and electric field |E|=100 V/m at 10 
Hz. 
51 
 
        Surface charge fluctuations: In aqueous solutions, the surface charge density of the 
glass fiber is determined by the intrinsic surface properties but also by the balance in the 
adsorption and desorption of various molecular and ionic species in the solutions. The latter 
will result in surface charge fluctuations, leading to fluctuations in the oscillation amplitude 
of the fiber. If the total number of surface charges is N, then the fluctuation in the total 
surface charge is on the order of e, and the corresponding fluctuation in the surface 
charge density is e/2πrl. For a clean silica surface, the surface charge density is ~1 
fC/µm2 [66], the total number of surface charge is 2x109 electrons for a fiber of 10 µm in 
diameter and 10 mm in length, the surface charge density fluctuation according to above 
formula is ~0.14 electron charges/µm2, close to the observed detection limit. 
        One way to examine the importance of the surface charge density fluctuation 
on the total noise of the measured oscillation amplitude is to study the noise vs. 
applied voltage.  According to Eq. (3.1), the noise in the oscillation amplitude in the 
direction of the electric field caused by surface charge density fluctuations is 
proportional to the applied voltage. We measured the amplitude noise parallel to the 
electric field vs. the applied voltage, and found that it indeed increased linearly with 
the voltage (Figure 3.8B). We also determined the amplitude noise perpendicular to 
the electric field (Figure 3.8C), which shows only a weak dependence with the 
voltage. These observations indicate that the noises in the oscillation amplitude are 
primarily due to the fluctuations in the surface charge density of the fiber. 
N
N
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Figure 3.8  Detection limit and noise analysis of CSOD. The root-mean-square of the noise 
level in the amplitude is 0.25 nm (A). Fiber diameter: 20 µm, length: 10 mm. Dependence 
of noise in the oscillation amplitude on the applied voltage in the parallel (B) and 
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perpendicular (C) directions of the field. Fiber diameter: 10 µm, length: 7 mm. Buffer for 
above experiments: 40 times diluted 1X PBS buffer. 
        Charge screening: The detection limit for xs in our preliminary experiments is 0.25 
nm, corresponding to an effective charge detection limit of ~0.25 electron charge/µm2. 
Ionic screening will reduce the effective charge, and thus affect the actual detection limit. 
The screening factor, defined as the ratio of the effective charge to the actual charge, is 
calculated as a function of ionic concentration with the Debye-Hückel theory. The 
screening factor depends on the non-slipping layer thickness (non –slipping layer defines 
a layer of water that moves with the fiber). The calculation shows that despite the ionic 
screening substantial effective charge remains even at relative high ionic concentration. 
Such screening depends on the ionic concentration as shown in Figure 3.9. For a 100 mM 
ionic solution, the ionic screening will reduce the effective charge to ~10% of the actual 
surface charge, leading to a detection limit of ~2.5 electron charges/µm2. 
 
Figure 3.9   Ionic screening and effective surface charge density (presented as the ratio of 
the effective surface charge to the actual charge). 
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3.5.2 Dynamic Range 
        The dynamic range of a detection technology is determined by the ratio of the 
maximum to minimum binding signals it can measure. In the present detection technique, 
the minimum signal is determined by random charge fluctuations, which is about ~0.25 
electron charge/µm2. The maximum signal is limited only by the size of view of the optical 
imaging system. Since we can also lower the driving electric field (i.e., lower the gain), the 
estimated upper limit is ~2.5 x 107 electron charge/µm2, leading to an extremely large 
dynamic range (~108). However, the actual upper limit in the signal is likely to be 
determined by how many molecules can pack to the surface of the fiber. Assuming a 
packing density of 106 molecules/µm2, the dynamic range would be 106-107. This dynamic 
range is superior to other detection technologies, including FET and EIM mentioned above.     
3.5.3 Immunity to Interference and Temperature Drift 
        Note that FETs mentioned above are sensitive to various processes other than charge, 
such as binding-induced capacitance changes, and ionic impurity trapping in the electronic 
materials and interconnections due to the complex biological media.  In contrast, only the 
optical fibers are inserted in the media and the detection is performed optically outside of 
the solution well.  
        An additional benefit of the present detection technique is its temperature stability. 
The FETs and SPR are sensitive to temperature because the charged carriers in the FETs 
and refractive index measured by SPR are strongly temperature dependent. The technique 
measures the fiber oscillation, which is insensitive to temperature drift (Figure 3.10). To 
examine possible temperature effect on the performance, the temperature of solution in the 
well and the oscillation amplitude of the optical fiber were simultaneously measured. 
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Figure 3.10A plots the temperature of a solution well within 10 min, which shows ~0.2 °C 
of temperature drift of the setup. This temperature drift did not cause any detectable 
changes in the oscillation amplitude of the optical fiber. The buffer solution was heated up 
to 29 °C and then cooled down. This relative large temperature variation did not produce 
any detectable drift in the oscillation amplitude either (Figure 3.10B), which demonstrates 
excellent temperature stability of the detection platform. However temperature does affect 
the binding kinetics because of the fundamental thermodynamics of molecular binding 
processes. 
 
Figure 3.10  Temperature Effect. (A) Drift of ambient lab temperature did no effect the 
fiber oscillation amplitude. (B) Heating and cooling over a large temperature range (4 °C) 
did not cause a drift in the fiber oscillation amplitude either. Fiber length: 9 mm, diameter: 
20 µm. Buffer: 40 times diluted 1X PBS buffer. Vpp = 6 V @ 55 Hz. 
3.5.4 Repeatability 
        The technique shows good repeatability among different fibers for molecular 
interaction measurement. The repeatability is dependent on the repeatability of sample 
preparation, i.e. etching of fiber probe, surface modification of fiber probe. To demonstrate 
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the repeatability, both large and small molecule binding experiments were repeated three 
times on three different optical fibers respectively. 
Anti-BSA and BSA 
        Three optical fibers were prepared following the same procedure (see Experimental 
Section for details). Briefly, amine coated fibers were incubated in 2.5% 1, 5-
Glutaraldehyde for 15 min and then in 0.1 mg/ml BSA for 1 h 15 min. Figure 3.11 shows 
the responses of the three optical fibers to 10 µl 0.5 mg/ml anti-BSA (final concentration 
of 215 nM). The results are similar to each other, demonstrating the repeatability of the 
present detection technique. 
 
Figure 3.11   Measurements anti-BSA binding to BSA with three different optical fibers. 
The black arrows mark the addition of 10 µl buffer for control, the red arrows mark the 
additions of 10 µl 0.5 mg/ml anti-BSA (final concentration of 215 nM), and the blue arrows 
indicate the change of the solution back to buffer. Fiber length: 8.5 mm, diameter: 22 µm. 
Vpp = 4 V @ 20 Hz. 
 
Imatinib and c-Abl 
Figure 3.12 shows the binding of imatinib to c-Abl for three different optical fibers. 
Fibers were modified with c-Abl through 1, 5-Glutaraldehyde according to the procedure 
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described in the Methods part. The responses of the three optical fibers to 10 µl 500 µM 
imatinib (final concentration of 15 µM) are similar, further demonstrating good 
reproducibility of the setup. 
 
Figure 3.12  Measurements of small molecule (imatinib) binding processes with three 
different optical fibers (A, B and C). These fibers were modified with c-Abl. The black 
arrows mark the addition of 10 µl buffer, the red arrows mark the additions of 10 µl 500 
µM imatinib (final concentration of 15 µM), and the blue arrows indicate the change of the 
solution back to buffer. Fiber length: (a) 7 mm, (b) 7.5 mm,  (c) 7.5 mm. Fiber diameter: 
(a) 11 µm (b) 13 µm, (c) 12.6 µm. Vpp = 2 V @ 40 Hz. 
3.5.5 Concentration Dependence 
    To demonstrate that the present detection technique can measure different 
concentrations of analyte, amine-coated optical fibers were modified with BSA via 1, 5-
Glutaraldehyde to measure anti-BSA of different concentrations. The fibers were first 
coated with amine by APTES (see Methods part), and then BSA by incubating them in 2.5% 
1, 5-Glutaraldehyde for 15 min and in 0.1 mg/ml BSA for 1 h. Right after the BSA 
modification, binding of the fibers to different concentrations of anti-BSA were measured 
and the oscillation amplitude change before and after anti-BSA addition vs. anti-BSA 
concentration was plotted in Figure 3.13. The experiment data (dots) were fitted with the 
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Langmuir isotherm, 𝑦 =
𝑦𝑚𝑎𝑥∙𝑐
𝐾𝐷+𝑐
, where y, c, and KD are the oscillation amplitude change, 
anti-BSA concentration and dissociation constant, respectively. KD was found to be 2.5 nM 
from the fitting, which is in agreements with other studies. 
 
Figure 3.13  Response curve of BSA-coated optical fiber to different concentrations of 
anti-BSA, where the dots are experimental data, and solid line is a best fit of the data to the 
Langmuir isotherm.  
3.5.6 Towards High Throughput Detection 
        One of the most important advantages of the present detection technique is its 
compatibility with the standard microplate platform, consisting of either 96, 384 or 1536 
wells. Unlike most microarray platforms, each of the well is chemically isolated from other 
wells, preventing cross talking and cross contamination.  
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Figure 3.14  High throughput detection using an optical fiber bundle (A). Simultaneously 
measured oscillation displacement (B) amplitude (C) of each fiber over time. 
Fiber bundles  
        In order to demonstrate high throughput capability, we created an optical fiber bundle 
consisting of 15 optical fibers manually. Each fiber is 1 cm long with its plastic coating 
stripped off to expose the silica cladding surface. The fiber bundle was used as a probe and 
dipped into a well of the 96-well plate containing 0.5 mM NaOH. Figure 3.14 shows the 
ends of 9 optical fibers from the bottom of the well through an inverted optical microscope 
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with a 4X objective. Figures S4 b and c show the oscillation displacement and amplitude 
of the individual fibers over time. The voltage applied was a sinusoidal wave with 20 V of 
amplitude and frequency of 20 Hz. 
Automated system for multiple well analysis 
        The optical bundle probe can be moved from one well to another, controlled with a 
computer-controlled automation setup to perform high throughput screening tests The 
control system can be programmed, which moves the optical fiber probe vertically in and 
out a well, and horizontally from one well to another well for multiple step analysis. The 
time scale achieved with the setup is 2 s, limited by the motor used in the current setup. 
Figure 3.15 shows fast and reproducible amplitude signal as we switched the fiber probe 
in and out between two solution wells. 
 
Figure 3.15  Automated switching of the optical fiber probe between two wells in a 
microplate. 
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3.6 Conclusion 
        We have validated the working principle of a detection technique based charge-
induced mechanical response with optical fibers, demonstrated its application for the 
detection of both large and small molecules, and evaluated the detection limit. The method 
is based on the detection of the charge, so that the output signal does not decrease with the 
molecular mass. The optical fibers used here are commercially available fibers for optical 
communications, which are uniform, pure and inexpensive. The setup is based on the 
conventional microplate platform, making it suitable for high throughout applications, 
especially when multiple fiber probes are used and automatically switched among different 
wells. The detection system is based on the conventional optical microscope, which has 
been shown to be simple and low noise. Using a differential optical detection and FFT 
filters, the charge detection limit is only limited by the surface charge fluctuations 
associated with the fundamental molecular and ionic binding processes taking place on a 
surface. We anticipate that the optical fiber-based technique become a useful tool for high 
throughput study of molecular interactions, for detection of disease biomarkers and for 
discovery of drugs. 
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CHAPTER 4 
KINETICS OF SMALL MOLECULE INTERACTIONS WITH MEMBRANE 
PROTEINS IN SINGLE CELLS MEASURED WITH MECHANICAL 
AMPLIFICATION 
4.1 Introduction 
Advances in structural biology have led to an exponential growth in the number of 
membrane proteins with determined 3D structures [67]. However, in order to understand 
the cellular functions of membrane proteins, it is also necessary to determine the interaction 
kinetics of the membrane proteins with various molecules. This is because cells perform 
many functions, including communication, via the interactions of their membrane proteins 
with molecules in the extracellular medium. A capability to quantify membrane protein 
interactions with molecules is also critical for discovering and validating drugs because 
most drug targets are membrane proteins [68, 69]. Despite the importance, developing such 
a capability that can measure the interactions of molecules with membrane proteins in the 
natural lipid environment has been a difficult task. 
The traditional method for studying molecular interactions uses radioactive or 
fluorescent labels. These end point assays do not provide kinetic constants that are needed 
to quantify the membrane interactions and functions [70, 71]. To determine the kinetic 
information, the current practice involves extracting membrane proteins from cells, 
purifying them from the extracts, immobilizing the purified proteins on a solid surface, and 
then exposing them to a ligand for kinetic study [72]. The procedures are not only laborious, 
but also prone to alteration of the native functions of membrane proteins, especially integral 
membrane proteins that are permanently attached to the membrane. Furthermore, the 
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isolation of membrane proteins from their native cellular environment prevents one from 
studying the allosteric effect in the molecular interactions[73], and examining 
heterogeneous nature of cells [74, 75]. Measurement of binding kinetics of membrane 
proteins on cells [76] or lipid bilayers [77, 78] has been demonstrated with surface plasmon 
resonance (SPR) and SPR with novel nanostructures, such as nanoparticles and nanopores. 
However the limitation of these technologies is that the detection signal diminishes with 
the mass of the molecule, making them difficult for detecting small molecules, which play 
many important roles in cellular functions, and represent the vast majority of the existing 
drugs.  
In this chapter we report an observation of mechanical deformation of cells upon 
interactions of the cellular membrane proteins with molecules in the extracellular medium, 
and demonstrate a capability of real time analysis of the interactions in single cells by 
analyzing the mechanical deformation with sub-nm resolution. We refer to this method as 
mechanically amplified detection of molecular interactions (MADMI). Using this 
capability, we have monitored the kinetics of both large and small molecule interactions 
with membrane proteins, including glycoproteins and ion channels in intact cells (fixed or 
live), and obtained the binding kinetic constants. For large molecules, the kinetic constants 
agree with those obtained with a plasmonic imaging technique. For small molecules, the 
present method represents the first kinetic measurement, and direct comparison with other 
techniques is not possible, but the equilibrium constants extracted from the present method 
are consistent with those obtained with endpoint radioactive labeling assay. The imaging 
capability allowed us to reveal cell-to-cell variability of difference cells, and region-to-
region variability within the same cell. 
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4.2 Detection Principle  
The principle to measure the mechanical deformation in the cellular membrane 
associated with the binding of molecules with the membrane proteins are illustrated in 
Figure 4.1. The mechanical deformation is expected because the law of thermodynamics 
predicts that when molecules bind to a surface, the surface tension changes, leading to a 
mechanical response in the cell membrane (Figure 4.1 E). According to thermodynamics, 
the surface concentration (Г) of molecules bound on the membrane surface is given by 
Г = −
𝑑𝛾
𝑑𝜇
                                                            (4.1) 
at a fixed temperature and pressure, where 𝛾 is the surface tension and 𝜇 is the chemical 
potential of the molecules. For ideal solutions, the chemical potential is related to the bulk 
concentration, c, according to 
𝑑𝜇 = 𝑅𝑇𝑑(ln 𝑐),                                                     (4.2) 
where R is the gas constant, and T is temperature. From Eqs. (4.1) and (4.2), at given 
concentration of analyte, molecular binding is directly proportional to the surface tension 
change, and one can thus determine the molecular interactions with the membrane proteins 
by measuring the mechanical deformation in the membrane (Figure 4.1 C). Note that 
according to Eq. (4.1) the mechanical deformation detected here does not depend on the 
size of the molecule, so the method works for both large and small molecules.  
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Figure 4.1 Detection of molecular interactions with membrane proteins in cells via 
mechanical amplification. (A) Schematic illumination of the setup based on an inverted 
phase contrast microscope with 40X phase 2 objective was used for detection. (B) 
Differential optical detection for accurate tracking of cell edge change induced by analyte 
receptor interaction. (C) Schematic of a typical binding curve as determined from the cell 
edge movement. (D) The root mean square of the fixed cell edge change is 0.46 nm.  (E) 
Illustration of cell edge changes over time during the binding process, where i, ii, and iii 
correspond to the stages marked in (C). Blue and red rectangles in (B) and (E) are the 
regions of interest for differential detection. 
4.3 Differential Optical Detection and Experimental Setup 
To detect the binding of a small amount of molecules, it is critical to be able to 
measure a small mechanical deformation in the cell membrane. Although Atomic Force 
Microscope (AFM) could, in principle, be used to measure cell deformation [79-81], we 
developed a simple method by tracking the edge movement of a cell with an optical 
microscope using a differential detection algorithm. Compared to AFM, it is non-invasive 
and fast, allowing multiple cells to be measured simultaneously. The differential detection 
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algorithm allowed us to achieve a detection limit of 0.5 nm of cell edge movement, the size 
of an atom, with millisecond temporal resolution (limited only by the frame rate of the 
CCD camera). 
        Figure 4.1A shows a schematic illustration of the experimental setup based on an 
inverted optical microscope. An inverted microscope (Olympus X81) equipped with a 
phase 2 condenser and phase 2 40X objective was used with illumination from the top of 
the sample cells. The edge of a cell is clearly revealed with conventional phase contrast 
optical imaging, as shown in Figure 4.1B. A rectangular region of interest (ROI) is defined 
such that the edge of a cell passes through the center of the rectangle, dividing the ROI into 
two equal halves, one half is inside of the cell, and the second half falls outside of the cell. 
We denote the intensities of the two halves as A and B. If the cell expands upon molecular 
binding (Figure 4.1C), then A decreases and B increases (Figure 4.1E). We measure 
differential image intensity, (A-B)/(A+B), and use it to determine the movement of the cell 
edge at each location. The relation between the cell edge movement and (A-B)/(A+B) was 
determined and calibrated using the following procedure. The pixel density of each image 
was increased by 5 times by adding additional pixels with a bilinear interpolation approach. 
The distance between two pixels in the interpolated image was 37 nm (Pike F032B CCD, 
Allied Vision Technologies, Stadtroda, Germany). The edge of one cell was manually 
chosen and the centroid (O) of the cell was determined (Figure 4.2A). A polar coordinate 
system was set up with the centroid serving as the pole. The cell edge movement was 
calculated at every 1 μm starting from 0˚ (Figures 4.2 A and B). The ROI at a certain point 
of the cell edge (point A) was then shifted by different numbers of pixels outwards 
(perpendicular to the tangential line at point A), and the corresponding changes in the 
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differential image intensity was determined from the image. The relation between the 
differential image intensity and the cell edge movement (pixels) was found to be linear 
within a certain range, which served as a calibration curve to determine the cell edge 
movement (mechanical deformation) from the differential image intensity. By following 
the cell edge movement, we obtain the binding kinetics as illustrated in Figure 4.1C. 
 
Figure 4.2 Calibration of the differential imaging intensity and cell edge movement. (A) 
The boundary (green line) of the cell was chosen manually and the centroid (red dot) of the 
cell was determined with an imaging-processing algorithm. (B) and (C) A region of interest 
(ROI) was chosen at every 1 μm along the cell boundary from 0˚ in the polar coordinate 
system where cell centroid was the pole. ROI in c is 4.6 μm away from that in B. Scale bar: 
10 μm. 
        We refer to this method of edge tracking as differential optical detection. The 
differential optical detection subtracts out common noise in the optical system, thus 
providing superior detection limit. Figure 4.1 D plots the noise level over time, showing a 
standard deviation of 0.46 nm.  Although we focus on phase contrast imaging in the present 
work, this optical detection algorithm can be readily applied to other optical imaging modes, 
such as bright field [82] and surface plasmon resonance. 
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4.4 WGA and Glycoprotein Interaction 
        To demonstrate the capability of the method for detecting and quantifying the 
interactions of molecules with the membrane proteins, we first studied molecular binding 
to glycoproteins. Glycoproteins are the most abundant membrane proteins with sugar 
groups extended into the extracellular space of the cells, which is critical in cell recognition 
and communication with various signaling molecules via specific interactions [83]. An 
important example of the specific interactions is between lectins, proteins that bind to and 
recognize specific sugar structures, and glycoproteins on the cell membranes. We studied 
wheat germ agglutinin (WGA), a lectin that can specifically recognize N-
acetylglucosamine (GlcNAc) and sialic acid groups on Barrett’s esophagus derived CP-D 
(CP-18821) cells. The CP-D cell were cultured in an incubator at 37˚C with 5% CO2 and 
70% relative humidity. Cells were cultured in 25 cm2 flask with 1x Keratinocyte-SFM (Life 
Technologies, Carlsbad, CA) and penicillin-streptomycin (BioWhittaker, Basel, 
Switzerland) as culture medium. When cells reached approximately 80% confluent, cells 
were passaged with 0.05% trypsin-EDTA (Life Technologies, Carlsbad, CA). For 
experiments, cells were cultured overnight on the bare glass slides (22×60 mm micro cover 
glass, VWR, Radnor, PA) in a silicone well (FlexiPERM, Greiner bio-one, Monroe, NC) 
placed on top of it in order to let cells attach on the surface. Cells on glass slides were also 
cultured in the incubator at 37 with 5% CO2 and 70% relative humidity. Cells were 
incubated in 4% paraformaldehyde for 10 min at room temperature for fixation and then 
ready for experiments. Before the measurement, the small silicone well was changed to a 
homemade PDMS well with 2 cm in length, 1 cm in width and 1 cm in height. 
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Figure 4.3 Large molecule interactions: WGA interaction with glycoproteins. Phase 
contrast images of fixed CP-D cells for 20 μg/ml (A) and 5 μg/ml WGA (B) binding, 
respectively. The white arrows mark the cells under analysis. The averaged cell edge 
movement over the whole cell (black dots) and global fitting (red curves) for 20 μg/ml (C) 
and 5 μg/ml (D) WGA, respectively. Scale bar: 10 μm. 
        Figures 4.3 A and B show the phase contrast images of CP-D cells attached to a glass 
slide. The measurement was carried out by first flowing 1X PBS over the cells with a flow 
rate of 350 μL/min for 30 s to obtain a baseline. WGA in 1X PBS was then introduced for 
90 s to allow the binding or association of WGA with the glycoproteins on the cell surface. 
During the association process, the cell edge moved outwards as shown in Figures 4.3 C 
and D. After the association process, the flow of the WGA solution was switched to 1X 
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PBS to allow the bound WGA to dissociate from the cells. Figures 4.3 C and D show that 
the cell edge moved back to the original position during the dissociation process. By 
globally fitting the data with the first order kinetics, the association rate constant (kon), 
dissociation rate constant (koff), and dissociation constant (KD) were found to be kon = 1.1 ×
105 𝑀−1𝑠−1, koff = 2.2 × 10−3 𝑠−1 and KD = 0.019 𝜇𝑀. WGA binding to glycoproteins 
on live cells was also detected with the same method (Figure 4.4). The results from both 
fixed and live cells are in good agreement with those obtained with plasmonic imaging 
method reported by us recently [76].  
        Another example is the binding of anti-EGFR antibody to EGFR on A431 cells. 
Epidermal growth factor receptor (EGFR) is a transmembrane receptor that is related to a 
variety of cancers and regulates cell proliferation, apoptosis and invasion. Monoclonal 
antibodies (mAb) targeting the extracellular domain of EGFR has shown good therapeutic 
efficacy for treatment of a number of cancers. The binding kinetics between mAb and 
EGFR is critical to determine the drug efficacy. We measured the mAb and EGFR 
interaction in fixed A431 cells with the present method. The association rate constant, 
dissociation rate constant and dissociation constant were obtained by fitting the 
experimental data with first order kinetics. The dissociation constant obtained from the 
kinetics study matches the reported value [84]. Unlike the plasmonic imaging method, 
which is difficult for measuring small molecules, the present mechanical amplification can 
detect both large and small molecules. 
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Figure 4.4  WGA and glycoprotein interactions in a live cell. (A) Phase contrast image of 
live SH-EP1 cell. Scale bar: 10 μm. (B) The average cell edge movement over the whole 
cell (black dots) and the fitting result (red curve) for 20 μg/ml WGA binding. By fitting the 
data with the first order kinetics, the association rate constant (kon), dissociation rate 
constant (koff), and dissociation constant (KD) were found to be kon = 1.0 × 104 𝑀−1𝑠−1, 
koff = 1.3 × 10−3 𝑠−1 and KD = 0.13 𝜇𝑀.   
 
Figure 4.5  Anti-EGFR antibody interaction with EGFR in cells. (A) Phase contrast image 
of fixed A431 cells, where the numbers mark the cells under analysis. Scale bare: 20 μm. 
(B) and (C) Averaged cell edge movement over the whole cell (black dots) for cells 1 (B) 
and 2 (C) respectively (10 nM anti-EGFR antibody). The red curves are fitting results 
according to the first order kinetics. The association rate constant (kon), dissociation rate 
constant (koff) and dissociation constant (KD) were found to be kon = 2.62 × 106 𝑀−1𝑠−1, 
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koff = 1.73 × 10−2 𝑠−1  and KD = 6.6 𝑛𝑀  for cell 1, kon = 1.97 × 106 𝑀−1𝑠−1 , koff = 
1.50 × 10−2 𝑠−1 and KD = 7.6 𝑛𝑀 for cell 2, respectively. 
4.5 Acetylcholine and Nicotinic Acetylcholine Receptors (nAChRs) Interaction 
        In order to demonstrate small molecule binding detection capability with the present 
method, we studied the binding of acetylcholine with nicotinic acetylcholine receptors 
(nAChRs) using engineered SH-EP1 cells that expressed human α4β2 receptors. nAChRs 
are among the most studied membrane receptors because of their critical role in 
neurotransmission and nicotine addiction [85, 86]. Determining the binding kinetics of 
neurotransmitters, such as acetylcholine, with nAChR in neurons is important for basic 
neuroscience, and for the clinical evaluation of nicotine addiction [87]. The 
neurotransmitter-receptor binding affinity cited in textbooks and literature was obtained 
with the radioactive labeling method, which requires lysis of the neurons [88], and 
incubation with the neurotransmitters, which cannot measure the binding affinity of each 
individual cells. Because radioactive or other labeling methods are end point assays, they 
do not provide kinetic constants. 
        The human α4β2 transfected human epithelial SH-EP1 cells were cultured in a 
humidity incubator at 37˚C with 5% CO2 and 70% relative humidity. Dubelco’s Modified 
Eagle’s Medium (DMEM, Lonza, Walkersville, MD) with 10% Fetal Bovine Serum (FBS, 
Life Technologies, Carlsbad, CA) and penicillin-streptomycin (BioWhittaker, Basel, 
Switzerland) were used as culture medium. SH-EP1-h α4β2 cells were cultured in 25 cm2 
flask until approximately 80% confluence was reached for passage. 0.05% trypsin-EDTA 
(Life Technologies, Carlsbad, CA) was used for cell passage. For experiments, cells were 
treated same as CP-D cells described in section 4.4. 
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        The image of SH-EP1-hα4β2 cells is shown in Figure 4.6A, where the white arrow 
marks the cell under analysis. 1X PBS buffer was first introduced to flow over the cell for 
25 s, and then the buffer was switched to an acetylcholine solution in 1X PBS. After 
association, the acetylcholine solution at each concentration was switched back to 1X PBS 
to allow for dissociation. The above procedure was repeated for different acetylcholine 
concentrations. As shown in Figure 4.6B, the cell edge expands during the association 
phase and retracts during the dissociation phase. Figure 4.5B also shows that the amount 
of cell expansion during the association process increases with the acetylcholine 
concentration, which is expected for first-order binding kinetics. The association (kon) and 
dissociation (koff) rate constants were found to be 1.2 × 10−6 𝑀−1𝑠−1 and 2.2 × 10−2 𝑠−1, 
respectively, which represent the first direct measurement of the kinetic constants for the 
binding of the neurotransmitter to the nAChRs in intact cells. From kon and koff, the 
equilibrium dissociation constant (KD= koff/kon) was determined to be 18.1 𝑛𝑀. By plotting 
the equilibrium response versus acetylcholine concentrations (Figure 4.6C), the 
equilibrium constant (KD) was found to be ~26 𝑛𝑀, which is consistent with that obtained 
by kinetics measurement. As this is the first kinetic measurement of acetycholine binding 
to nAChRs, we cannot compare our findings to other reference technologies or prior data. 
However, the equilibrium dissociation constant determined here is in good agreement with 
the average Ki determined with radioligand binding assay, which involved centrifuge and 
formation of cell pellets [88, 89].  
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Figure 4.6 Small molecule interactions: Acetylcholine interaction with nicotinic 
acetylcholine receptors in cells. (A) Phase contrast image of the fixed human α4β2 
transfected SH-EP1 cells, where the white arrow marks the cell under analysis. Scale bar: 
20 μm. (B) Averaged cell edge movement over the whole cell (black dots) and global fitting 
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results (red curves) during the binding process for acetylcholine of different concentrations 
(from bottom to top: 1 nM, 5 nM, 20 nM, and 100 nM). (C) Cell edge movement at 
equilibrium vs. acetylcholine concentration. The equilibrium constant (KD) was determined 
to be ~26 nM by fitting the data with the Langmuir isotherm.  
        As a control experiment, we carried out the measurement with wild type SH-EP1 cells, 
which do not have nAChRs expressed on the cell surfaces, and observed no deformation 
in the cell membrane (Figure 4.7). The expression levels of nAChRs in the engineered and 
wild type cells were confirmed with immunofluorescence imaging. The engineered cells 
were incubated with both primary and Alexa Fluor 488 labeled secondary antibodies. The 
typical phase contrast and immunofluorescence images of the engineered SH-EP1 cells are 
shown in Figure 4.8 A and D. Negative control was carried out by incubating the wild type 
SH-EP1 cells with primary and secondary antibodies (Figure 4.8 B and E). Another 
negative control was performed by incubating the engineered SH-EP1 cells with only 
secondary antibody (Figure 4.8 C and F). There are a little fluorescence signals in both 
negative controls, which confirms high coverage of  nAChRs in the SH-EP1-hα4β2 cells. 
These results demonstrated that the mechanical deformation in the engineered SH-EP1 
cells was indeed due to the specific binding of acetylcholine to the expressed nAChRs. 
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Figure 4.7  Negative control. (A) Phase contrast images of wild type SH-EP1 cells. Scale 
bar: 20 μm. (B) Response of wild type SH-EP1 cells to 500 nM acetylcholine. The red 
arrow marks the switch from 1x PBS to 500 nM acetylcholine and the blue arrow indicates 
the change of solution back to 1x PBS. 
 
 
Figure 4.8  Phase contrast (A – C) and immunofluorescence (D – F) images of nAChRs 
positive and negative cells.  Positive control was performed by sequentially incubating 
human α4β2 transfected SH-EP1 cells with primary and secondary antibodies (A and D). 
First negative control was followed the same procedure with the wild type SH-EP1 cells 
(B and E). Second negative control was performed by incubating the human α4β2 
transfected SH-EP1 cells with secondary antibody only (C and F). Scale Bar: 20 μm. 
 
 
 
 
77 
 
Table 4.1 Association rate constants (kon), dissociation rate constants (koff), and 
equilibrium constants (KD) for four cells as shown in Figures 4.9 A to D. 
 
 
 
 
 
         
        The present method can not only to quantify the binding kinetics of small molecule 
interactions with membrane proteins in single cells, but also examine the cell-cell 
variations in the binding kinetics. Figures 4.9 A and C are the phase contrast images of SH-
EP1-hα4β2, where the numbers in circles mark the cells under analysis. Cells 1 and 2 were 
cultured on one glass slide, and cells 3 and 4 on a second glass slide. The responses of these 
cells to 100 nM acetylcholine are shown in Figures 4.9 B and D, and the corresponding 
kinetic constants are given in Table 4.1, which show significant differences in the binding 
kinetics among the cells. The method also allows us to examine the binding kinetics at 
different regions of the same cell. Figure 4.9E plots the binding kinetic curves of 
acetylcholine to nAChRs at various locations of a cell, which shows large variations in the 
binding kinetics. Figure 4.9F shows the maximum membrane deformation along the edge 
of a cell, where the color represents the deformation in nm. Heterogeneous distribution of 
membrane protein receptors in cells play important roles in cellular functions, including 
interactions between different cells [74, 75]. 
 kon (𝑀−1𝑠−1) koff (𝑠−1) KD (𝑛𝑀) 
Cell 1 7.32 × 105 0.0161 22.0 
Cell 2 8.33 × 105 0.0217 26.1 
Cell 3 3.42 × 105 0.0298 87.1 
Cell 4 5.76 × 105 0.0172 29.9 
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Figure 4.9 Heterogeneity of small molecule interactions with cell membrane receptors. (A 
and C) Phase contrast images of fixed human α4β2 transfected SH-EP1 cells, where the 
numbers mark different cells under analysis. Scale bar: 20 μm. (B) Binding kinetics of cells 
1 and 2 (100 nM Acetylcholine). (D) Binding kinetics of cells 3 and 4 (100 nM 
Acetylcholine). (E) Binding kinetics at different locations of cell in f (100 nM 
Acetylcholine). (F) Phase contrast image of fixed human α4β2 transfected SH-EP1 cell. 
The color represents the amount of cell membrane edge deformation. Scale bar: 20 μm.       
4.6 Discussion 
        The importance of studying molecular interactions with membrane proteins has 
motivated many efforts to develop label-free detection technologies for real time analysis 
of the interaction kinetics. Examples include quartz crystal microbalance [90] and surface 
plasmon resonance (SPR) techniques [76]. However, the signals of both methods are 
proportional to the mass of the molecule, making them difficult to measure the kinetics of 
small molecule interactions with membrane proteins. To our knowledge, this work is the 
first direct and real-time measurement of the binding kinetics of small molecules with 
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membrane proteins in intact cells without labeling. The method is based on the law of 
thermodynamics, which is general and applicable to analyzing the interactions of both large 
and small molecules with membrane proteins.  
In addition, mechanical amplification and the sub-nm resolution offered by the 
differential detection algorithm provide sensitive detection of molecular binding in single 
cells. The sub-nm scaled detection limit can be further improved by removing noise from 
different sources. Figure 4.10 shows the noise power spectrum of the cell edge movement 
of a cell. At low frequencies (< 10 Hz), the power spectrum can be fitted with a linear 
function with a slope close to -2, indicating Brownian motion as the major source of noise. 
However at higher frequencies, it deviates significantly from the Brownian noise behavior, 
which shows noise from other sources, such as light source and camera, become important. 
 
Figure 4.10 Noise power spectrum of cell edge movement of a fixed CP-D cell. The cell 
edge movement was measured with the differential detection algorithm. The slope at low 
frequencies is close to -2, as expected for Brownian motion. 
The spatial resolution at single cell level allows us to quantify not only cell-to-cell 
variability in the binding kinetics (Figures 4.9 A to D), but also region-to-region difference 
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within a single cell. For example, Figure 4.9 F shows relative larger binding signals of a 
cell in the regions where the cell interacts with a neighboring cell (red color in Figure 4.9 
F). Similarly, the corresponding regions of the neighboring cell also show larger binding 
signals then other regions (Figure 4.11 A). This phenomenon has also been observed in 
other cells (Figure 4.11 B).  
 
Figure 4.11 Molecular binding-induced membrane deformation along cell edges. (A) 
Phase contrast image of fixed human α4β2 transfected SH-EP1 cell adjacent to the cell in 
Fig. 4F. (B) Phase contrast image of fixed human α4β2 transfected SH-EP1 cell. Color 
represents the amount of cell membrane deformation after acetylcholine binding. Scale bar: 
20 μm. 
        Finally, the method is based on optical microscopy, which is simple and compatible 
with various optical imaging techniques, including fluorescence imaging. These 
capabilities will benefit the screening of the drugs, and understanding of various cellular 
processes that involve membrane proteins. The latter is especially important because as the 
number of 3D structures of membrane proteins increases exponentially, studying the 
interaction kinetics of molecules with the membrane proteins becomes increasingly 
important.  
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CHAPTER 5 
REAL TIME MONITORING GRANULE RELEASE BY MEASURING PLASMA 
MEMBRANE DEFORMATION 
5.1 Introduction 
        One way of cellular communication is regulated exocytosis. In nerve systems, signals 
are transmitted from one neuron to another by the neurotransmitters released from pre-
synapses to the post-synapses through regulated synaptic vesicles exocytosis. When an 
action potential depolarizes the presynaptic plasma membrane, Ca2+ channels open, and 
the influx of Ca2+ results in the elevation of Ca2+ concentration, thus triggering the 
exocytosis of synaptic vesicles [91, 92]. Vesicles release the neurotransmitters into the 
synaptic cleft, and then are captured by receptors on the post-synapses, thus initiating a 
sequence of downstream reactions [93]. Vesicle exocytosis mainly takes two forms, full 
fusion or “kiss and run” [94-96]. In full fusion, vesicles fuse with plasma membrane and 
fully collapse into plasma membrane, leading to an increase in plasma membrane area. 
Vesicles also transiently fuse with plasma membrane and release their neurotransmitter, 
after which the vesicles retrieve for reuse. In immune system, mast cells which contain 
granules rich in histamine, serotonin and heparin play an important role in a variety of 
allergic, asthmatic and inflammatory reactions [97, 98]. Mast cells express high affinity 
immunoglobulin E (IgE) receptors (FcεRI) on cell surfaces which can be sensitized after 
IgE binding [99]. Upon specific antigens binding to FcεRI bound IgE, a signaling cascade 
initiates including the degranulation, which is the secretory of characteristic granules of 
mast cells [100]. Granules dock at the plasma membrane and when degranulation is 
activated, granules fuse with plasma membrane which results in histamine, serotonin, 
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heparin and other inflammatory mediators releasing into extracellular solution which 
causes characteristic symptoms of an allergic reaction. 
        At present, exocytosis is mainly studied by electrophysiological recording and 
fluorescence imaging at the single cell level [101, 102]. Capacitance measurements by 
single cell patch clamp are based on the fact that exocytosis increases the plasma membrane 
because of fusion of vesicles or granules, which thus increases the plasma membrane 
capacitance [103, 104]. Capacitance measurements is limited by taking the overall effects 
of exocytosis on the whole cell and thus cannot pin out the exact release location. Another 
way is to record the oxidation current of electric active chemicals released from vesicles or 
granules. A carbon microelectrode a constant potential is placed close to the cell membrane 
to monitor exocytosis [105-108]. When there is exocytosis, the released chemicals, for 
example dopamine or histamine, are oxidized at the electrode and thus the oxidization 
currents are recorded showing spikes in the signal. Amperometric measurements monitor 
the release of secretory products and is limited on measuring vesicles or granules 
containing electric active compounds. Individual exocytosis has also been studied by 
fluorescence imaging [109]. Some pH sensitive dyes [110-112] (for example, Acridine 
Orange, FITC-dextran) accumulate inside the acidic vesicles. When the fusion between the 
vesicle membrane and plasma membrane happens during the exocytosis, the dyes inside 
the vesicles are exposed to the neutral pH extracellular medium. This exposure will relieve 
the low-pH quenching dyes in the lumen of secretory vesicles and thus resulting in bright 
spot in fluorescent image. Fluorescent styryl FM dye has been used to track exocytosis, 
endocytosis and label firing neurons [109, 113, 114]. FM dye is virtually nonfluorescent in 
aqueous solution, while it is intensively fluorescent when inserted in plasma membrane. 
83 
 
Fluorescence imaging suffers the low temporal resolution because of photo bleaching of 
fluorophores. 
        Here I used the RBL-2H3, a rat basophilic leukemia cell line as the model system to 
study degranulation process. I report an observation of mechanical deformation of cell 
plasma membrane during the granule exocytosis triggered by antigen and IgE interactions, 
and demonstrate a capability of real time analysis of granule release by tracking the cell 
edge and the deformation propagation from the granule release location to cell edge. I have 
directly observed the plasma membrane mechanical response after degranulation is 
activated. Using this capability, I have monitored the granule release and mapped the cell 
membrane deformation caused by the granule fusion. The cell membrane deformation has 
been confirmed to be related by granule release by simultaneous fluorescence recording. 
Temporal and spatial correlation of membrane deformation has been carefully analyzed. 
The delay between membrane deformation and fluorescence signal has been observed and 
explained. Granules diameters were calculated based on the measured cell edge expansion 
to be from 100 nm to 200 nm. This imaging capability allows me to analyze the spatial 
distribution of cell membrane deformation. 
5.2 Materials and Methods 
        RBL-2H3, a basophilic leukemia cell line isolated and cloned from Wistar rat 
basophilic cells, has been used as a model system to study the IgE mediated degranulation 
of mast cells. RBL-2H3 cells were purchased from American Type Culture Collection 
(ATCC). RBL-2H3 cells were cultured in a humidity incubator at 37˚C with 5% CO2 and 
70% relative humidity. Eagle’s Minimum Essential Medium (EMEM, ATCC 30-2003) 
with 15% heat inactivated Fetal Bovine Serum (FBS, Life Technologies, Carlsbad, CA) 
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and penicillin-streptomycin (BioWhittaker, Basel, Switzerland) were used as culture 
medium. RBL-2H3 cells were cultured in 25 cm2 flask until approximately 80% confluence 
was reached for passage. 0.05% trypsin-EDTA (Life Technologies, Carlsbad, CA) was 
used for cell passage.  
        For experiment, cells were cultured overnight in 35 mm diameter tissue culture petri 
dish (Corning Inc., Corning, NY). The complete culture medium mentioned above together 
with 200 μM serotonin (Sigma-Aldrich, St. Louis, MO), 0.5 μg/ml monoclonal anti-
Dinitrophenyl (anti-DNP) IgE (Sigma-Aldrich, St. Louis, MO) and 1 mg/ml fluorescein 
isothiocyanate-dextran (FITC-dextran, molecular weight 150,000, Sigma-Aldrich, St. 
Louis, MO) were used for culturing. Serotonin was used to increase the size of granule 
[115]. High affinity IgE receptors (FcεRI) are expressed on the cell surface to which anti-
DNP IgE binds to. When the antigen, 2,4-dinitrophenylated albumin from bovine serum 
(DNP-BSA, Life Technologies, Carlsbad, CA) was added, the binding of DNP-BSA to 
anti-DNP IgE will make the cross-linking of FcεRI which initiates a signaling cascade 
leading to degranulation of the cells and release of chemical mediators. FITC-dextran 
accumulates inside the granules and are quenched by the weak acidic granule luminal 
solution. When degranulation is activated, the FITC-dextran is exposed to the neutral pH 
extracellular solution along with the released chemicals and thus the quenching is relieved 
giving a bright spot as fluorescence signal. Before measurement, the cells were rinsed three 
times with 0.1% BSA in extracellular buffer (135 mM NaCl, 5 mM KCl, 20 mM HEPES, 
1.8 mM CaCl2, 1 mM MgCl2, 5.6 mM glucose, pH = 7.4) for three times to block the 
surface followed by another three times wash with extracellular buffer only. The petri dish 
with cells in 1 ml extracellular buffer was moved on the microscope for imaging. Recording 
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of both phase contrast and fluorescent images was right after addition of 1 ml 5 μg/ml 
DNP-BSA into the petri dish. 
 
Figure 5. 1 Detection principle of granule release by tracking the edge deformation of cells. 
(A) Schematic illumination of the imaging setup based on an inverted phase contrast 
microscope with 40X phase 2 objective. A top light passes through a long pass filter with 
600 nm cut-on wavelength (f1) and illuminates on sample cells. Phase contrast images are 
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recorded by a camera after another long pass filter with 600 nm cut-on wavelength (f4). A 
set of optical filters (excitation 420 nm – 480 nm (f2), emission 515 nm (f3)) is used for 
fluorescence imaging. A shutter is used to block both phase contrast and fluorescence light 
for synchronization. (B) Phase contrast image of RBL-2H3 cells. The red arrow marks the 
position where there is a granule release. (C) Illustration of cell edge changes during the 
granule release, measured by differential detection method. Red and blue rectangles are the 
region of interest for differential detection. (D) Fluorescence image of RBL-2H3 cells at 
the same location shown in (B). The bright spot pointed by the red arrow is due to the 
fluorescence from granule release. (E) The fluorescence image after the background 
subtraction. The bright spot pointed by the red arrow is due to a granule release. Scale bar: 
10 μm. 
        An inverted microscope (Olympus IX81) equipped with a phase 2 condenser and 
phase 2 40X objective was used with illumination from the top of the sample cells (Figure 
5.1A). Top illumination light pass through a long pass filter with 600 nm cut-on wavelength 
before illuminating on cell sample. The phase contrast image was recorded by a 
Hamamatsu camera with frame rate of up to 400 fps after another long pass filter with 600 
nm cut-on wavelength. A set of optical filters (Ex420-480/Em515) was used for the 
fluorescence imaging and another Hamamatsu camera was used for recording with frame 
rate of 8 fps. 
5.3 Phase Contrast and Fluorescence Simultaneous Recording and Optical Differential 
Detection  
        To investigate the plasma membrane behavior during the granules release, as well as 
to validate the release by fluorescence, the experimental setup based on an inverted optical 
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microscope was used (Figure 5.1A). Top illumination light pass through a long pass filter 
with 600 nm cut-on wavelength before illuminating on cell sample to avoid lighting up the 
fluorescence background. The phase contrast image was recorded after another long pass 
filter with 600 nm cut-on wavelength in order to eliminate the fluorescent signal in phase 
contrast image. A set of optical filters (Ex420-480/Em515) was used for the fluorescence 
imaging. With the modification of the microscope, the phase contrast image and 
fluorescence image are able to be obtained simultaneously of the same location. FITC-
dextran was used as a reporter to validate the granule release. Figures 5.1 B and D show 
the phase contrast image and the corresponding fluorescence image at the same location, 
respectively. The edge of the cells can be clearly resolved with conventional phase contrast 
image (Figure 5.1B). To track the edge deformation, a rectangular region of interest (ROI) 
is defined such that the edge of a cell passes through the center of the rectangle. The 
rectangular ROI is divided into two equal halves, with one half inside of the cell and the 
other half outside of the cell (Figure 5.1C). We donate the intensities of the two halves as 
A and B. If the cell plasma membrane deforms (for example expanding) when granule 
releases, A will decrease, while B will increase (Figure 5.1C). The difference between A 
and B, (A-B)/(A+B), is used to determine the movement of the cell edge at each location. 
The calibration between (A-B)/(A+B) and the cell edge movement is determined 
experimentally.  We refer to this method of detecting edge movement as differential optical 
detection. The differential detection rejects the common noise in optical system, thus 
providing high detection limit.  The red arrows in both Figures 5.1 B and D point out the 
location where there is a granule release. The bright spot in Figure 5.1D is due to that the 
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elevated pH relieves low-pH quenched FITC in secretory granule when granule fuses with 
the cell plasma membrane during exocytosis.  
        To synchronize the phase contrast image and fluorescent image recording, a shutter is 
used to cut off the light path to black out both images (Figure 5.1A). By carefully aligning 
the intensity plots of fluorescent and phase contrast images, the two recordings are 
synchronized (Figure 5.2). 
 
Figure 5.2 Synchronization between phase contrast and fluorescence recording. The 
shutter is used to block the light path of both fluorescence and phase contrast imaging. The 
time is aligned and synchronized when the shutter is removed. 
5.4 Granule Release Measured By Tracking Cell Edge Deformation 
        To demonstrate the capability of tracking the cell plasma membrane deformation 
during granule exocytosis, the cells were first labeled by FITC-dextran and the release was 
triggered by DNP binding to anti-DNP IgE on cell surface. Figure 5.3A plots the edge 
deformation at the location marked by the black arrows in Figures 5.3 B to E, which are a 
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sequence of phase contrast images of the cell corresponding to the time marked by B, C, D 
and E in Figure 5.3A respectively. The cell edge expands very quickly and which shows a 
stepwise increase in edge tracking plot in Figure 5.3A. The total time for the cell plasma 
membrane expansion of ~ 18 nm is 0.18 s.  Figure 5.3B shows the fluorescence intensity 
over time and the insert shows the cell fluorescent image with the bright spot marked by 
the white arrow which is due to the granule release. The fluorescent intensity increases 
sharply within 0.125 s because the granule fuses with the cell plasma membrane and thus 
the low-pH quenched FITC is exposed to the neutral pH extracellular medium which 
dequenches the dye. The gradual decrease in fluorescent intensity is due to the diffusion of 
FITC. Figures 5.3 G to J shows the fluorescent images after background subtraction before 
granule and plasma membrane fusion (Figure 5.3G), during fusion (Figure 5.3H), and the 
diffusion of FITC (Figures 5.3 I and J). Note that the time of the fluorescent signal peak is 
a little ahead of the plasma membrane expansion, we will come back to discuss this later. 
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Figure 5.3  Principle demonstration: granule release measured by edge tracking and 
validated by fluorescence imaging. (A) Cell edge deformation over time at the location 
marked with the black arrows in (B-E) and white arrows in (G-J). (B-E) Snapshots of phase 
contrast images at the times marked by the letters B, C, D and E in figure (A), respectively. 
The red dashed lines depict the cell contour. (F) Fluorescence intensity within the region 
marked with yellow dashed circle in the inset and figures (G-J) is plotted over time. Inset: 
fluorescence image of the cell and the cell edge is depicted by red dashed line. The white 
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arrows in figures G-J and the black arrows in figures B-E are pointed to the same location 
of the cell. (G-J) Snapshots of fluorescence images of the cell after subtracting the 
background. The time of those images are marked by letters G, H, I and J in figure F, 
respectively. The red dashed lines depict the cell contour. Scale bar: 10 μm. 
        To confirm the observed membrane expansion is related to the granule release, we 
examined the membrane deformation at other locations along the cell edge during the same 
time period. Figure 5.4A shows the phase contrast image of the cell where B, C and D 
marks the location shown in Figure 5.4 B, C and D respectively. Only at the location where 
there shows the fluorescent signal the cell membrane expands (Figure 5.4C). 
 
Figure 5.4  Cell edge movement tracking at different locations along the cell edge. (A) 
Phase contrast image of a RBL-2H3 cell. The blue and red rectangles are regions of interest 
(ROI) that mark the locations labeled by letter B, C, and D. (B-D) Cell edge movement at 
the locations marked by B, C and D, respectively. Scale bar: 10 μm. 
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5.5 Localized Cell Membrane Deformation Due to Granule Release 
        The image capability allows us to examine the how localized the cell membrane 
deformation is. Cell membrane expansion amounts from 5.25 s to 5.75 s (Figure 5.4C, 
difference between the two red lines) at different locations are calculated. Figure 5.5A is 
the phase contrast image of the cell under analysis. Figure 5.5B shows the deformation at 
different locations along the cell edge and the color represents the deformation in nm. The 
cell edge expands most at the location where there shows the fluorescent signal of granule 
release (bright spot in Figure 5.5C). To take a close look, the cell edge movement at 
locations between the two red arrows along the cell edge in Figure 5.5A are plotted in 
Figure 5.5C. The cell membrane expands differently with the variation of locations. Figure 
5.5D plots the amount of stepwise membrane deformation along the cell edge marked by 
red arrows in Figure 5.5B.  The location marked by the right red arrow is set to be zero 
shown in Figure 5.5D. The cell membrane expansion is distributed as that the larger 
responses are at the locations closer to the fluorescent signal (bright spot) and decays with 
the distance between the cell edge and fluorescent bright spot. The stepwise cell membrane 
expansion is localized to the cell edge closest to the fluorescent signal due to granule 
release, which supports the plasma membrane expands when the granules fuse with plasma 
membrane. 
        A sequence of snapshots of cell phase contrast images as well as the membrane 
deformation along the cell edge (represented by color) are shown in Figure 5.5 A. The cell 
edge deformation is compared to the original status set at time = 4.5 s. The membrane 
doesn’t show clear deformation until time = 5.250 s. An expansion at the cell edge pointed 
by black arrow begins to show at time = 5.375 s and quickly become very obvious within 
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a short period of time (0.125 s). This expansion stays there though the total expansion 
region shrinks (time = 5.750 s and 6.000 s). Figures 5.6 B and C are the 3D and 2D plots 
respectively, showing the cell membrane deformation from time = 4.5 s to 6.3 s along the 
edge from red arrow to blue arrow pointing locations. The color in both figures represents 
the deformation in nm. At around 5.5 s, a reddish region appears which means the cell edge 
expands. Later on, the color becomes yellow which means the cell edge goes back a little 
but not completely to the baseline. Note that the reddish region also becomes narrow over 
time, which matches the observation that the expansion region shrinks. 
 
Figure 5.5  Local cell edge deformation caused by granule release. (A) Phase contrast 
image of RBL-2H3 cells. (B) The cell edge movement at different locations marked with 
green dots between two red arrows in figure (A). (C) Fluorescence image of granule release 
(location is pointed by the black arrow) in RBL-2H3 cell overlapped with corresponded 
local edge movement. The color represents the maximum amount of cell membrane edge 
94 
 
deformation in nm. (D) The cell membrane edge deformation in the region between the red 
and blue arrows in figure (C). Scale bar: 10 μm. 
 
Figure 5.6  Real time cell membrane deformation distribution. (A) Phase contrast images 
of RBL-2H3 cell at different time overlapped with the cell membrane movement at 
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different locations. The color represents the amount of cell membrane deformation in nm. 
Black arrow indicates the location where the cell membrane shows most obvious change 
over time. (B) 3D plot of cell edge movement over time in the region marked between red 
and blue arrows in figure (A). The color represents the cell edge movement in nm. (C) 2D 
plot of cell edge movement with x axis in time, y axis in position corresponding to (B). 
The region are between the cell edges indicated by the red and blue arrows in (A). The 
color represents the cell edge change in nm. Scale bar: 10 μm. 
5.6 Granule Release Location Dependent Time Delay 
        The simultaneous recording of phase contrast and fluorescent images allows us to 
examine the temporal relation between the cell membrane deformation and fluorescence 
signal. Figure 5.7 shows the cell membrane deformation and corresponding fluorescence 
signal of four different cells on different chips. Figures 5.7 E to H are the phase contrast 
images of the cells. Among these four cells, the cell membrane all expanded during the 
granule exocytosis and showed the stepwise increase in the cell edge tracking plot (Figures 
5.7 A to D). The color in Figures 5.7 E to L represents the amount of stepwise increase 
along the edge in nm.  The red color regions showing the expansion of the cell edge are 
localized to the bright spots of fluorescence signal (Figures 5.7 I to L). Note that the 
fluorescence peaks are always ahead of the plasma membrane expansion, however the 
ahead time varies among different cells. Figure 5.7A shows the longest time difference 
between the fluorescence signal peak and stepwise increase in edge deformation among 
the four cells, while Figure 5.7D shows the shortest time difference. Comparing the 
distances between the fluorescence bright spot center and maximum expansion location 
along the cell edge in Figures 5.7 I and L, it shows the longer distance in Figure 5.7 I gives 
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longer time difference in Figure 5.7A. To further investigate the distance dependent time 
delay, I plotted the time delay of membrane expansion to the fluorescence signal peak 
versus the distance between the fluorescence bright spot center and the largest expansion 
location along the cell edge (Figure 5.8). It shows very good linear relationship which 
confirms that the time delay is due the propagation of the effect of vesicle fusion to the cell 
edge. 
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Figure 5.7  Cell edge deformation and corresponded fluorescence signal on different cells. 
(A-D) The cell edge movements and corresponded fluorescence signals caused by granule 
release from different RBL-2H3 cells. The corresponded phase contrast and fluorescence 
images are shown in E/I, F/J, G/K, and H/L, respectively. The red arrows in E-H indicate 
the locations of the edge movement plotted in A-D respectively. (E-H) Phase contrast 
images of RBL-2H3 cells overlap with corresponded local edge movement. The color 
represents the amount of cell membrane edge deformation at different locations in nm. (I-
L) Fluorescence images of RBL-2H3 cells overlap with corresponded local edge movement. 
The color represents the amount of cell membrane edge deformation in nm. The granule 
release location is pointed out by black arrows in I-L. Scale bar: 10 μm. 
 
Figure 5.8  Granule release location vs. time delay. The locations of different granule 
release events are pin pointed from the fluorescence image (pointed by the black arrows in 
Fig. 5.7 I-L). Time delays between fluorescence signal and edge movement are measured 
from Fig. 5.7 A-D. The time delay linearly increases with the distance between granule 
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release location and cell edge. Squares are the experimental data and red line is the linear 
fitting. 
5.7 Granule Release and Plasma Membrane Deformation 
        According to capacitance measurements, the cell membrane area increases due to the 
fusion of granule with cell plasma membrane [116]. A model has been built to explain the 
process during vesicle exocytosis in full fusion mode [117, 118]. A secretory vesicle docks 
at the plasma membrane and then an initial fusion pore forms. The vesicle luminal 
chemicals diffuse outside to the extracellular solution, and thus the surface tension at two 
connected membranes builds up. When the energy at the edge of the initially formed pore 
is overloaded, the initial fusion pore expands. Chemical messengers stored inside the 
vesicle are released to the extracellular solution and the vesicle membrane is incorporated 
with cell plasma membrane and thus losing its identity. The incorporation of the vesicle 
into the cell increases the cell plasma membrane which results in the expansion of cell edge. 
By tracking the cell edge, we can directly observe the cell deformation due to the granule 
membrane fused into the plasma membrane. I did observe the edge expansion as the model 
predicted. Figure 5.9 illustrates the membrane expansion during the granule fusion. 
Initially the secretory granule docks at the plasma membrane (Figure 5.9A). After 
degranulation is triggered by IgE antibody dimerization due to antigen binding to IgE on 
the cell surface, an initial fusion pore appears and the granule begins to fuse with plasma 
membrane more and more, thus increasing the area of plasma membrane leading to the 
expansion at the cell edge (Figures 5.9 B and C). When the granule is completely fused 
with plasma membrane, the cell edge expands to maximum (Figure 5.9D).  This explains 
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the cell edge expansion and also predicts the delay of membrane edge expansion due to the 
propagation from the granule docking location to the membrane edge. 
 
Figure 5.9  Schematic illumination of a granule release process and the corresponded 
plasma membrane expansion at different stages. (A) A granule docks at the plasma 
membrane. (B) An initial pore forms after the degranulation is triggered. (C) The initial 
pore expands and results in the cell membrane expansion because the extra membrane of 
granule immerges into cell plasma membrane. (D) The final cell shape after full fusion 
completes and the plasma membrane expands to maximum. Note that the membrane of and 
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from granule is showing with yellow color, and the dashed line in figure C and D indicates 
the original cell membrane position. 
 
Figure 5.10  Plasma membrane indentation before granule fusion. (A) Cell Membrane 
edge moves over time. The white arrow in figure (C) indicates the location analyzed for 
the plot. A decrease in edge movement marked by two red lines is just ahead of granule 
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fusion. (B) Corresponded fluorescence signal of figure (A). (C) Phase contrast image of 
RBL-2H3 cell overlaps with the corresponded local edge movement. The color represents 
the membrane deformation amplitude between time t1 = 4 s and t2 = 4.5 s. (D) 
Fluorescence image of the same RBL-2H3 cell in (C). The color represents the membrane 
deformation amplitude between time t1 = 4 s and t2 = 4.5 s.  (E) The SEM images show 
the plasma membrane indents when a granule comes to dock there. Figure E is from [119]. 
Scale bar: 10 μm. 
        I also observed that before the expansion of cell membrane, there is a decrease in cell 
edge deformation which means the indentation of cell membrane. The stepwise decrease 
along the cell edge is plotted in Figures 5.10 C and D, and color presents the cell membrane 
indentation in nm. Note that the indentation of cell edge is also localized to the location 
closest to the fluorescent signal of granule release (bright spot in Figure 5.10D). This 
phenomenon was also observed by SEM (Figure 5.10E [119]) that when granules are 
transported to dock at the plasma membrane, the cell membrane sometimes will dent. 
However this rarely happens and the mechanism is not clearly known. 
5.8 Granule Size  
        The expanded edge is due to the granule membrane fusing with cell plasma membrane. 
To calculate the increased area, the maximum cell edge expansion was integrated along the 
cell edge. Also the volume of the granule was estimated by integrating the corresponding 
fluorescence signal over time. Granule area is proportional to 𝑟2, and granule volume is 
proportional to 𝑟3 , where r is the granule radius. Figure 5.11A shows the 
√𝑖𝑛𝑐𝑟𝑒𝑎𝑠𝑒𝑑 𝑎𝑟𝑒𝑎 calculated from edge tracking in the relation of  √𝑠𝑒𝑐𝑟𝑒𝑡𝑜𝑟𝑦 𝑣𝑜𝑙𝑢𝑚𝑒
3
 
estimated by fluorescence signal, and it is fitted with linear relation. The diameter also 
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shows good linear relationship with √𝑠𝑒𝑐𝑟𝑒𝑡𝑜𝑟𝑦 𝑣𝑜𝑙𝑢𝑚𝑒
3
 (Figure 5.11B). The calculated 
diameters ranges between 100 nm to 250 nm which is slightly smaller than the literature 
reporting 500 nm [120]. This could be due to that the edge expansion calculated is from 
the 2D cell image projected from 3D cell.  
 
Figure 5.11 Correlation between edge expansion amplitude and fluorescence.  (A) Square 
root of increase area calculated form edge tracking vs cube root of secretory volume 
estimated from fluorescence signal. Black square: experimental data. Red line: linear fitting. 
(B) Calculated granule diameter from edge tracking vs cube root of secretory volume 
estimated from fluorescence signal. Black square: experimental data. Red line: linear fitting. 
5.9 Conclusion 
        I have demonstrated that by tracking the cell edge membrane deformation, I observed 
single granules release in single cells. Unlike fluorescence, amperometric and capacitance 
measurements, I directly observe the plasma membrane response to the granule fusion in 
real time with 2.5 ms time resolution and nm sensitivity. The pre-fusion indentation of 
plasma membrane when granule is transported to the membrane is also able to be imaged. 
With this edge tracking method, I can measure the membrane deformation distribution 
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along the cell edge which is due to the granule secretory. The time delay between 
fluorescence and cell edge deformation has been observed, which shows the membrane 
deformation propagation from the granule release location to the cell edge. The granules 
size is also estimated from the edge tracking signal. 
        This method provides a simple, label free way to monitor the exocytosis process. 
Focusing on plasma membrane mechanical deformation help understanding some basic 
characteristics of exocytosis besides the molecular study. This method is not limited to the 
cell types and is promising for label free study of synaptic vesicle release. 
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CHAPTER 6 
CONCLUSIONS AND PERSPECTIVE 
      For the charge sensitive optical detection (CSOD), I have built the microscope based 
platform and demonstrated the capability of detection small molecules and proteins 
interactions. The next step is to realize the high-throughput capability of this method. 
CSOD is designed for high-throughput detection as it is compatible with microplate, which 
benefits the sample handling a lot. In order to achieve it, we are building a setup based on 
position sensitive diodes (PSD) to detect the optical fiber tip oscillation. By doing this, we 
can have 8 optical fibers as detection probes simultaneously detecting molecular 
interactions.  
      I have successfully detected small molecules interacting with membrane proteins by 
tracking cell membrane deformation. To our knowledge, it is the first time to real-time 
detect small molecule binding to membrane proteins in situ. Now the experiments were 
executed on fixed cells. The next step, first is to apply this method to live cells and even 
tissues. It is important because live cells and tissues are closer to the in vivo situation. 
Second, facing the situation that thousands or even hundreds of thousands chemical 
structures need to be screened in one day, it is essential to have high-throughput capability. 
Though now this image based method allows some throughput, it is not enough. To 
combine this method with flow cytometry will have large impact on both increasing 
throughput of this method and adding an extra parameter in flow cytometry measurement. 
Third, the accurate differential edge tracking method can be used to monitoring cell 
membrane deformation caused by other cellular activities, for example, exocytosis. When 
cells secrete vesicles, the vesicle membrane interacts with the cell plasma membrane, for 
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example, full fusion or kiss-and-run. These activities result in cell plasma membrane 
deformation. By tracking the plasma membrane change, we can detect the secretory 
process without labeling. Therefore we can detect the events with fast sampling rate 
without fluorescence limitation. The direct measurement of cell plasma membrane 
provides further understanding of cell exocytosis process.  
        I have demonstrated by tracking the cell plasma membrane deformation, I 
successfully observed the granule release from the cell. The pre-fusion indentation of 
plasma membrane when granule is transported to the membrane is also able to be imaged. 
With this edge tracking method, I can measure the membrane deformation distribution 
along the cell edge which is due to the granule secretory. The time delay between 
fluorescence and cell edge deformation has been observed, which shows the membrane 
deformation propagation from the granule release location to the cell edge. The size of the 
vesicle is also estimated from the edge tracking measurement. This is a label free imaging 
method, and the cell activities won’t be affected by label molecules or extra perturbation. 
This method could be applied to detect the synaptic vesicle release in neural network.   
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